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AO An acronym for the German “Arbeitsgemeinschaft für 
Osteosyntesefragen”, the predecessor of the AO Foundation 
BMD   Bone mineral density 
BMI   Body mass index 
CD   Celiac disease 
CRF   Clinical risk factor 
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FRAX®  WHO fracture risk assessment tool 
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TG2   IgA antibody against Tissue Transglutaminase 2 
IPAQ   International Physical Activity Questionnaire 
T-SCORE Number of SDs by which BMD in an individual differs from the 
mean value expected in healthy young women 
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Fractures are a substantial burden for both individuals and society. For the individual it 
leads to pain, reduced quality of life, disability and increased mortality. For society, it 
carries a great cost and requires substantial resources. With the increasing age in the 
population, this burden is expected to increase. There is potential to prevent more 
fractures than we do today by increased knowledge about groups at risk and individual 
risk factors, both through awareness, case finding in defined populations, and targeted 
treatment in the case of osteoporosis.  
Aim 
The overall aim of this thesis is to contribute to better fracture prevention through 
increased knowledge of risk factors and patient groups at risk, focusing on celiac 
disease, osteoporosis and obesity as risk factors for peripheral fractures. 
Materials and methods 
The dissertation is based on a case control study of consecutive patients with acute 
ankle- or distal radius fracture treated at the Helse Førde Hospital Trust in Norway, 
March 2014- January 2017, and community-based controls.  
Results 
Our findings are presented in four papers. The first paper is a review on celiac disease 
and risk of fractures in adults. Previous studies performed on the subject were 
heterogeneous and difficult to compare, but the overall findings indicate a positive 
association between celiac disease and risk of fracture. We concluded that adult 
patients with celiac disease should be considered for bone densitometry in order to 
estimate fracture risk, thus enabling fracture prevention.  
In the second paper we report the prevalence of positive IgA transglutaminase 2 
(TG2), a marker for both subclinical and clinically active celiac disease, and celiac 
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disease in patients with distal radius or ankle fracture compared to community-based 
controls. We found that 2.5 % of the fracture patients had positive TG2, compared to 1 
% in the control group, but the results did not show significantly increased odds of 
fracture. This study indicates that universal screening for celiac disease in fracture 
patients is not warranted, but that diagnostic tests should be performed in case of 
additional factors present increasing the patients’ risk of having celiac disease.  
The aim of the study reported in the third paper was to determine whether radiographic 
complexity of a distal radius fracture can be used to see if different distal radius 
fracture subtypes differ with regard to the prevalence of osteoporosis. When 
classifying the fractures according to the AO-classification system, we found no 
association between the severity of distal radius fractures and osteoporosis, hereby 
challenging a common perception that such an association exists.  
The study reported in the fourth paper investigated associations of overweight, obesity 
and osteoporosis with ankle fracture and the Danis-Weber (D-W) ankle fracture 
classification. We concluded that overweight increased the odds of ankle fractures and 
the odds of sustaining an ankle fracture with possible instability (D-W type B and C). 
Osteoporosis did not significantly increase the odds of ankle fracture, nor the odds of 
an instable distal fibula fracture. 
Conclusion 
Understanding the impact common medical conditions such as osteoporosis, celiac 
disease and obesity have on fracture risk is important in order to identify and treat 
people at risk. This dissertation aims to expand the knowledge in this research 
landscape, look into and challenge the perception of common clinical beliefs, and 





SAMMENDRAG PÅ NORSK 
Bakgrunn 
Beinbrudd utgjør en stor belastning både for individ og samfunn. For den det rammer, 
fører brudd til smerte, redusert livskvalitet, potensielt også til uførhet og økt mortalitet. 
Ressursbruken i samfunnet er enorm. Parallelt med økende aldring i befolkningen, 
forventes en betydelig økning i bruddforekomst, og dermed også i den økonomiske og 
menneskelige belastningen. Økt fokus på og kunnskap om risikofaktorer kan 
forebygge flere brudd enn tilfellet er i dag, både hos enkeltindivid og på gruppenivå. 
Det finnes effektive medikamenter som kan redusere bruddrisiko ved diagnostisert 
osteoporose, som er den sterkeste risikofaktor for brudd, bortsett fra kvinnelig kjønn 
og økende alder.  
Mål 
Hovedmålet med denne avhandlingen er å bidra til bedre bruddforebygging i daglig 
klinisk praksis gjennom økt kunnskap om pasientrelaterte risikofaktorer for brudd, 
med fokus på cøliaki, osteoporose og overvekt. 
Kilder og metode 
Avhandlingen er basert på en case kontroll studie som inkluderte pasienter med akutt 
brudd i ankel eller distale radius, behandlet i Helse Førde i perioden mars 2014 til 
januar 2017, samt kontroller fra Sogn og Fjordane fylke.  
Resultater 
Resultatene presenteres i 4 artikler. Den første artikkelen var en oversiktsartikkel som 
omhandler cøliaki og risiko for brudd hos voksne. Studiene på dette feltet var ulike 
både i design, metodologi og størrelse, og er vanskelige å sammenligne. Det er likevel 
tilstrekkelig kunnskap til å konkludere med en positiv assosiasjon mellom cøliaki og 
bruddrisiko. Konklusjonen i vår oversiktsartikkel er at voksne pasienter med cøliaki 
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bør vurderes for beintetthetsundersøkelse, og bruddforebyggende behandling 
igangsettes dersom indisert.  
I den andre artikkelen undersøkes prevalens av positiv IgA transglutaminase 2 (TG2), 
en blodprøvemarkør for både subklinisk og aktiv cøliaki, og cøliaki hos pasienter med 
distalt radiusbrudd eller ankelbrudd sammenlignet med kontroller uten brudd. 2.5 % av 
bruddpasientene hadde positiv TG2 sammenlignet med 1 % i kontrollgruppen, men 
konfidensintervallet var stort. Vi konkluderer med at generell serologisk screening for 
cøliaki hos alle bruddpasienter ikke er indisert, men at terskelen for å analysere TG2 
bør være lav dersom det er tilleggsfaktorer som gjør at cøliaki mistenkes. 
Den tredje artikkelen belyser hvorvidt radiografisk kompleksitet av et distalt 
radiusbrudd kan si noe om sannsynligheten for osteoporose. Vi grupperte 
radiusbruddene ved hjelp av et klassifikasjonssystem fra vanlig klinisk praksis (AO), 
og konkluderer med at det ikke var en sammenheng mellom økende kompleksitet i 
følge AO grupper og større odds for osteoporose. Vi utfordrer dermed en eksisterende 
oppfatning om en slik mulig sammenheng.  
I den fjerde artikkelen ser vi på faktorer som gir økt risiko for ankelbrudd. Vi ser også 
på faktorer som påvirker plasseringen av den distale fibulafrakturen etter Danis-Weber 
klassifikasjonen. Studien viser at overvekt øker risiko både for ankelbrudd og for 
instabilitet av ankelbruddet (økt risiko for D-W type B og C sammenlignet med A). 
Osteoporose ga ikke sikkert økt risiko for ankelbrudd eller bruddinstabilitet.  
Konklusjon 
Å forstå hvordan vanlige medisinske tilstander som osteoporose, cøliaki og overvekt 
påvirker bruddrisiko er viktig for å kunne identifisere de med økt risiko, og dermed 
behandle og forebygge brudd. Denne avhandlingen bidrar til økt kunnskap på dette 
vide forskningsfeltet, og utfordrer vanlige oppfatninger om faktorer som innvirker på 
bruddrisiko. Et mål med avhandlingen var også å bidra til utviklingen av nye praktiske 
retningslinjer til daglig bruk og nytte for klinikere. 
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1. INTRODUCTION 
Fractures lead to increased risk of death, pain and disability for the individual, and 
cause an enormous economic burden for societies [1]. The etiology is multifactorial. 
Most fractures occur as a result of a fall or other trauma. A fragility fracture is usually 
defined as a pathological fracture that results from minimal trauma (e.g. a fall from a 
standing height) or no identifiable trauma at all [2]. Our bodies should be able to 
sustain a fall from this height without a fracture unless there is an underlying condition 
causing bone fragility. One in three women and one in five men over the age of 50 
worldwide will sustain a fragility fracture. The most common cause of fragility 
fractures is osteoporosis (“porous bone”). During the past two decades, a range of 
medications has become available for the treatment and prevention of osteoporosis, 
and these have proved to reduce the risk of osteoporotic fractures. However, there is a 
big treatment gap, as most patients still do not receive pharmacological intervention 
according to current recommendations for osteoporotic fracture prevention [3].  
Most fractures occur in individuals without osteoporosis [4], and fracture prevention 
measures therefore need to look beyond this specific risk factor. In order to prevent 
fragility fractures, we need increased knowledge and awareness concerning individuals 
and patient groups at risk. Active case finding, both in daily clinical settings and by 
society-based measures, can enable us to better prevent fractures. Subsequently, both 
disability, impaired quality of life and shortened life span for the individual, as well as 
the pressure on the health care systems can be reduced. 
   Design by Runar Hovland, for the FABB-study 
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       1.1 Fractures in adults 
A fracture occurs when a bone encounters an outside force that exceeds its strength. 
Distal radius, hip, humerus, ankle and vertebral fractures are among the most frequent 
fracture types in the adult population. According to the Swedish fracture registry’s [5] 
2018 annual rapport, for men over the age of 60, hip fractures constituted 30.5 % (11 
393 patients), fractures of the hand and distal radius 18.2 %, and ankle fracture 8.4 % 
of the fractures. For women over 60 years, the most frequent fracture was distal radius 
fracture with 21.0 % (19 357 patients), followed by hip fracture (25.3 %), proximal 
humerus fracture (11.7) and ankle fracture (7.8%). A peripheral fracture may lead to 
hospitalization, surgery, immobilization and disability, which again leads to increased 
morbidity and mortality [1].  
Fragility fractures are fractures that result from mechanical forces that would not 
ordinarily result in fracture, also called low energy trauma [6]. The main risk factors 
for fragility fractures are higher age, previous fracture, female gender, low bone 
mineral density (BMD), reduced bone quality, underweight, early menopause, 
smoking, excess alcohol-use, heredity, ethnicity, physical inactivity, falls, medical 
conditions and effects and/or side effects of medical treatment [7]. Regarding 
peripheral fractures, osteoporosis especially increases the risk of fracture of the hip [8] 
and the distal radius [9], and risk factors for fracture differ according to the various 
fracture sites in the body. When it comes to e.g. the ankle, it has not been clearly 
demonstrated that BMD or other bone quality related factors increase the risk of 
fracture (addressed in section 1.6), and there is a complex interplay with both external 
factors and individual biomechanical factors. 
1.2 Fragility fracture burden world wide 
Osteoporosis causes more than 8.9 million fractures annually worldwide, 
approximately 1000 per hour [1]. 3.5 million fragility fractures were sustained in the 
27 countries of the European Union (EU27) in 2010, comprising 610,000 hip fractures, 
520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures 
[1]. The economic burden of incident and prior fragility fracture in EU27 was 
 17
estimated to € 37 billion. Overall, women have about twice as high a risk of sustaining 
any fracture than men, but there are variations between different fracture sites. Two to 
three times as many women as men sustain a hip fracture, but the 1-year mortality rate 
for men is twice as high [10-13], possibly related to higher rates of comorbidity. 
Sustaining a fracture, depending on fracture type, may increase the risk of a secondary 
major osteoporotic fracture of the hip or vertebrae [14].  
There is a large difference in the incidence of fragility fractures worldwide, most 
pronounced in the case of hip fractures. The differences between countries are much 
greater than the differences in incidence between sexes within a county [15]. Fracture 
rates are higher in the western world than in other regions, and more than one-third of 
all osteoporotic fractures in the world occur in Europe [16]. Although there are some 
differences in the prevalence of osteoporosis between countries, they are quite small 
[17-19], indicating that the difference in fracture risk cannot solely be explained by 
differences in BMD. The risk factors for osteoporosis (e.g. underweight, low calcium 
intake, low exposure to sunlight, early menopause) do not explain differences in risk 
between countries either [1]. To illustrate the complexity, hip fracture rates in Norway 
are more than double that of Spanish women [1]. A small study found that Norwegian 
women had a significantly higher BMD than comparable Spanish women, but had a 
greater height (can increase the impact on bone in case of a fall). They also had 
impaired bone material properties [20]. Overall, the factor found to best predict the 
incidence of a major fracture in a population, is socioeconomic prosperity [21]. This 
may in turn be related to low levels of physical activity [21]. It still remains to fully 
understand which factors are responsible for the heterogeneity of fracture risk.  
The Scandinavian countries have some of the highest incidences of hip fractures in the 
world [15]. In Norway, despite declining incidence rates [22, 23], the absolute number 
of fractures is still increasing because of a growing number of older individuals [24]. 
A recent study estimating the future burden of hip fractures in Norway [25], indicates 
that health loss lost to hip fractures will approximately double, from 32,850 DALYs 
(disability adjusted life years) in 2020 to 60,555 in 2040. In addition, there is no trend 
towards decreasing incidence of a second hip fracture, indicating that secondary 
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fracture prevention needs to be improved [22]. Since hip fractures are a late 
consequence of osteoporosis with serious consequences for the patients, awareness of 
increased fracture risk should be addressed before the hip fracture, or another major 
osteoporotic fracture, occur.  
1.3 Concepts of bone, osteoporosis and bone mineral density 
Our bones are in a state of continuous remodeling to ensure their flexibility and 
stamina, and bone is a living, active tissue. Bone mass increases in youth until peak 
bone mass is reached (approximately 20 to 30 years of age), followed by a stable 
period in middle age [26, 27]. When the process of bone resorption (through the action 
of the osteoclasts) is dominant over the bone formation (action of the osteoblasts), the 
net result is bone loss over time. A gradual decrease in bone mass starts in women at 
approximately 50, and in men at about 65 years of age. The decrease becomes 
pronounced in women at menopause because of the loss of estrogen [28]. These 
changes in bone mass with aging are demonstrated in Figure 1: 
 
 
Figure 1: Relationship between age and bone mass in men and women [29].  
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The two basic types of bone are cortical and trabecular bone. Cortical bone forms the 
compact outer shell of all bones and the shafts of the long bones. It supports weight, 
resists bends and twists, and accounts for about 80 % of the skeletal mass in adults. 
Trabecular bone is the latticework structure within the bones that adds strength without 
excessive weight. It supports compressive loading in the spine, hip, and calcaneus, and 
it is also found at the ends of long bones, such as the distal radius [30].  
Osteoporosis is defined as “a disease characterized by low bone mass, micro 
architectural deterioration of bone tissue leading to enhanced bone fragility, and a 
consequent increase in fracture risk” [31]. According to The IOF (International 
Osteoporosis Foundation), the number of individuals aged 50 years and older with 
osteoporosis was 20 million in 2015 [32], hereunder approximately 7 % of men and 
22.5 % of women.  
In 1994 and 2008, the WHO published classification criteria for osteoporosis in 
postmenopausal women based on the T-score for BMD, defining osteoporosis as a T-
score less or equal to 2.5 standard deviations (SD) or below the young female adult 
mean BMD [33]. Osteopenia is defined as a T-score between -1.0 and -2,5 SD below 
the mean, and normal bone mineral density as a T-score equal or better than -1 SD 
below the mean (Figure 2).   
 T-score ≥ -1     Normal BMD   
 T-score < -1 and > -2.5   Low bone mass/osteopenia 
 T-score ≤ -2.5    Osteoporosis 
Figure 2:  T-score definitions of bone mineral density [33]. 
 
Ideally, the definition of the skeleton’s strength should also include parameters other 
than BMD, such as microarchitecture and geometric features, but this is not yet 
applicable for daily clinical practice. BMD is most commonly defined as the amount 
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of bone mass per unit area (areal density, g/cm2) [34]. The most widely used technique 
to measure BMD is dual energy x-ray absorptiometry (DXA) [35]. The principle is to 
use two different photon energies of the x-ray beams to optimize the differences in the 
x rays’ attenuating effects on soft tissue and bone [36]. The absorption of x-rays is 
very sensitive to calcium content in tissue. DXA provides a two-dimensional areal 
value, and is thus influenced by bone size as well as true density. DXA has the 
advantages of low radiation dose, being ease to use, having a short scan time, 
providing high-resolution images, high precision, and stable calibration. The most 
commonly measured sites are the lumbar spine (L1-L4) and the proximal femur, but 
also the radius and the whole body can be evaluated. The lumbar spine may be 
impaired by degenerative changes, vertebral deformities and extra-skeletal 
calcifications especially in the elderly, making the femoral neck the standard reference 
site for diagnosis [37].  
 
 
Figure 3: DXA Lunar Prodigy, GE. Permission by GE Healthcare Norge.                                                                                                                                             
1.4 Preventing fractures in adults 
General management to prevent fractures is a multifaceted task. Most fractures occur 
as a result of a fall, making fall prevention measures essential, especially in the 
elderly. Focusing on modifiable factors that increase the likelihood of fall is of 
essence. Impaired vision is a good example, as treatment of cataracts has been proven 
to reduce falls [38]. Other modifiable individual factors include exercise to improve 
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balance and skeletal health, ensuring adequate diet, avoiding age-related weight loss 
(hereunder loss of muscle mass), avoidance of smoking and excessive alcohol intake, 
and reducing the use of sedatives [1]. Environmental factors that can precipitate a fall 
in home dwellers include slippery flooring, loose carpet edges, inadequate footwear, 
and, on the society level, slippery roads and sidewalks, and difficult access to 
community services such as stores and public offices [1]. For institutionalized 
individuals, external factors such as facilitated modern buildings, appropriate beds and 
equipment are important in preventing falls. In addition, having a sufficient number of 
health personnel to assist the dwellers may reduce the risk of falls. 
Chronic medical conditions may increase the risk of falls, and optimizing the treatment 
of the illness at hand is key, e.g. preventing hypoglycemia in diabetics, reducing 
rigidity in patients with Parkinson’s disease, and reducing joint inflammation in 
patients with rheumatoid arthritis. Concerning inflammatory diseases, maintaining a 
low inflammatory activity may be beneficial for several reasons. One is that a chronic 
inflammation over time is a cause of secondary osteoporosis, another is that chronic 
inflammation may be an independent risk factor for fracture and falls [39].  
In the case of osteoporosis, there are pharmacological interventions widely available 
that effectively reduce fracture risk, and that have also been proven cost-effective. A 
combined supplement of calcium and vitamin D is beneficial for patients with 
osteoporosis, but the results on fracture rate reduction have been variable. Some 
studies have reported a reduction in fracture rate [40, 41], relative risk reductions for 
hip fracture ranging from 0.81-0.87 [42]. Vitamin D deficiency has also been linked to 
increased risk of falls. It may act as a driver of chronic inflammation, and the cause-
effect discussions when it comes to vitamin D deficiency and fractures are extensive 
[43]. A bisphosphonate (preferably oral alendronate, alternatively intravenous 
zoledronic acid) is usually the drug of choice when targeted treatment is indicated, but 
also denosumab, raloxifene, strontium ranelate, teriparatide and romosozumab are in 
current use for the treatment of osteoporosis for both postmenopausal women and men 
[44]. They are proven effective in preventing fractures, both as primary prevention, 
and as secondary prevention of the next major osteoporotic fracture [45-52]. There are 
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no head-to-head studies with fracture as the primary outcome, so direct comparison 
between agents is challenging. Generally, the reduction rate in vertebral fractures is 
larger than the demonstrated efficacy in preventing non-vertebral fractures [52]. The 
difference in fracture-preventing effect according to the fracture site can reflect the 
various drugs’ different effects on cortical and trabecular bone, but also the importance 
of falls in the pathogenesis of fractures. A limitation of the drug approving studies is 
that most large studies investigate fracture prevention in postmenopausal women with 
primary osteoporosis, and extrapolation of the results to other populations has its 
shortcomings.  
Despite effective medication being available, most individuals having sustained an 
osteoporosis-related fracture or who are at risk of such a fracture, remain untreated 
[53-55]. A recent study from eight countries across Europe found that 75 % of elderly 
women seen in primary care who were at high risk of fragility fractures were not 
receiving appropriate medication [56]. In Denmark, the gap between women eligible 
for antiosteoporotic treatment and those actually receiving treatment after a fracture 
remained stable at 88-90% in the 2005 to 2015 period [57]. In order to diminish this 
treatment gap, fracture liaison service models are effective measures, and are proven to 
be both cost-effective and to reduce mortality [58, 59]. Ortogeriatric care models are 
associated with higher rates of diagnosing osteoporosis and starting treatment. 
However, whether orthogeriatric care prevents subsequent falls and fractures, is not 
clear [60]. These initiatives are, however, mainly based upon preventing a second 
fracture from occurring, and are not suitable for primary prevention of osteoporotic 
fractures.  
1.5 Distal radius fractures 
In Norway, the annual around 15 000 distal radius fractures [61] constitute 
approximately 20 % of all fractures in adults [62]. The incidence is approximately four 
times higher in women than in men [63]. The prevalence of distal radius fracture in 
Norway is one of the greatest in the world, and is more than double the prevalence in 
e.g. the United States of America [64, 65].  
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The most common fracture of the distal forearm is the Colles’ fracture, caused by a fall 
on the outstretched arm, resulting in a dorsal misalignment [66]. If the patient falls 
with the hand in a flexed position, this will result in a fracture with a volar 
displacement, called a Smith’s fracture [67]. In addition to the distal radius, distal 
forearm fractures may also include a fracture of the ulna styloid process. Although 
such fractures are rarely fatal, the consequences are often underestimated, as the 
occurrence of a wrist fracture increases the odds of a clinically important functional 
decline in women by almost 50 % [68]. A recent study from the National Swedish 
fracture register found an overall 1-year mortality of 2.9 % after a distal radius 
fracture. In adults, the most typical patient is an elderly woman sustaining the fracture 
through a simple fall in her own residence [63].  
 Figure 4: Müller AO type A2 fracture (study participant) 
 
Distal radius fractures are closely related to low BMD [9], and are considered as 
osteoporotic index fractures since such patients have a higher risk of a major 
osteoporotic fracture later in life [69, 70]. A recent study found 86 % reduced risk of 
subsequent hip fracture after distal radius fracture in a 4-year follow up when active 
osteoporosis care was initiated [71]. A distal radius fracture in post-menopausal 
 24
women is recommended to lead to further evaluation with DXA and preventive 
measures for secondary fractures [72]. 
The most common radiological classification system of distal radius fractures in 
clinical practice is the Müller AO-system (AO) [73]. The Müller AO classification 
classifies fractures according to localization and fracture pattern [74].  Each fracture is 
given two numbers to describe which bone is affected and where in the bone the 
fracture occurs. A distal radius fracture is classified as 23. This number is followed by 
a letter describing the joint involvement; Type A is extra articular, type B is partly 
articular, and type C completely articular, supplemented further by division into 
subgroups. A simplified graphic of this is illustrated in Figure 5:  
 
 
     Type 23-A            Type 23-B                            Type 23-C 
Extraarticular fracture          Partial articular fracture          Complete articular fracture 
Figure 5: The Müller AO classification of distal radius fractures.  




  1.6 Ankle fractures 
An ankle fracture affects the distal tibia (shinbone), the distal fibula (outer bone of the 
lower leg), or both. The most common type of ankle fracture is a break of the lateral 
malleolus: the lower part of the fibula [75]. Ankle fractures constitute approximately 
every tenth fracture in adults [76, 77]. Ankle fractures are, in contrast to distal radius 
fractures, not considered to be classical osteoporotic fractures. Compared to patients 
with osteoporotic fractures of the hip, spine, and distal radius, patients sustaining an 
ankle fracture are typically younger [78], and have a higher BMI (body mass index) 
[79]. However, it has been shown that postmenopausal women with an ankle fracture 
have an increased risk of subsequent fracture [80], and approximately two thirds of the 
ankle fractures in adults result from a low-energy trauma [76].  
  Figure 6: D-W type B fracture (study participant). 
A commonly used classification of lateral malleolar fractures is the Danis-Weber 
classification (D-W) [81]. D-W type A fractures occur below the level of the ankle 
syndesmosis, leaving the syndesmosis and the deltoid ligament intact. The medial 
malleolus is occasionally fractured. Type B fractures are situated at the level of the 
ankle syndesmosis, the medial malleolus may be fractured, and the deltoid ligament 
may be torn, resulting in variable stability. Type C fractures occur above the level of 
the syndesmosis, the deltoid ligament is always torn, causing instability of the ankle 




Figure 7: The Danis-Weber classification of ankle fractures (types A, B and C). 
Type A: fracture of the lateral malleolus distal to the syndesmosis (usually stable). 
Type B: fracture of the fibula at the level of the syndesmosis (variable stability). 
Type C: fracture of the fibula proximal to the syndesmosis (unstable).  
Design by Eir Pétursdóttir 
1.7 Osteoporosis and risk of fracture 
It is highly relevant to make a distinction between the definition of osteoporosis based 
on BMD versus clinical findings; the occurrence of fragility fractures. Elderly persons 
with fragility fractures of the hip or vertebrae should be considered for osteoporosis 
treatment independent of the result of a DXA scanning. The indication for 
pharmacological treatment is hence not made on the basis of the BMD measurement 
alone, but is based on the patient’s individual fracture risk. This is in line with 
principles of treating other diseases, e.g. hypertension. The diagnosis is based on 
measurement of blood pressure, and the aim of treatment is to prevent stroke and 
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congestive heart disease over time. So, “normal” for age does not mean that the 
condition should not be treated, if the risk of complications is high. Large population-
based studies show that the risk of fracture increases by a factor of 1.5-3.0 for each SD 
decrease in BMD [8]. This means that the ability of BMD to predict fracture is 
comparable to the use of blood pressure to predict stroke [1]. There are, however, 
substantial differences between countries in how cost-effective treatment for 
osteoporosis is, due to the large differences in fracture risk in different populations 
[82]. It is also important to recognize that BMD alone has high specificity, but low 
sensitivity, meaning that the majority of osteoporotic fractures will occur in 
individuals with osteopenia or normal BMD [83].   
There are a large number of additional risk factors that provide information on fracture 
risk independently on both age, sex and BMD [1]. Particularly, it is important identify 
risk factors that are amenable to modification. The following clinical risk factors 
(CRFs) form the input to the fracture probability tool FRAX®: age, sex, low body mass 
index, previous fragility fracture, parental history of hip fracture, glucocorticoid 
treatment (≥5 mg oral prednisolone daily for 3 months or more), current smoking, 
alcohol intake 3 or more units daily, rheumatoid arthritis, and other established causes 
of secondary osteoporosis (hypogonadism, inflammatory bowel disease, prolonged 
immobility, organ transplantation, type I diabetes, thyroid disorders and chronic 
obstructive pulmonary disease) [84]. FRAX® models weigh these CRFs and estimate 
the 10-year probability for hip fracture or a major osteoporotic fracture, with or 
without a BMD T-score, according to which country the patient resides in [85]. This 
tool is widely used in daily clinical practice, and is a good supplement when treatment 
decisions are to be made. The probability of fracture calculated from FRAX® depends 
upon age and life expectancy as well as the current relative risk. Thus, where the risk 
of death is high, the probability of fracture will decrease for the same fracture hazard. 
Using FRAX®, men and women of the same age and the same BMD have similar 
fracture risk [84]. The somewhat higher probabilities in women are due to the longer 
life expectancy in women compared with men. A major limitation is that several of the 
CRFs used in FRAX® take no account of dose-response, but rather represent an 
average dose or exposure vs. non-exposure [1]. Additionally, there are CFRs not 
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incorporated in FRAX® that are very important when it comes to a person’s risk of 
fracture, the most apparent being previous falls. Furthermore, a range of other clinical 
conditions (e.g. celiac disease, irritable bowel syndrome, psoriasis and psoriatic 
arthritis, systemic lupus erythematousus, Parkinson’s disease) increase the risk of 
fractures [86-90]. This increased fracture risk is partly mediated by osteoporosis, but 
also by mechanisms like chronic inflammation and increased risk of falls. 
Correspondingly, medication other than glucocorticoids also increase fracture risk (e.g. 
sedatives [91], some antiepileptics [92], aromatase inhibitors [93]). For this reason, 
there is a need to further assess additional individual CRFs when attempting to 
estimate a patient’s fracture risk as accurately as possible. 
     1.8 Celiac disease and risk of fracture 
Celiac disease (CD) is an immune-based enteropathy characterized by malabsorption, 
small intestine villus atrophy, and antibodies to transglutaminase. CD is triggered by 
exposure to wheat gluten and similar proteins in rye and barley, and affects genetically 
susceptible persons [94]. It is a common disease, especially in Scandinavia, Ireland, 
and the United Kingdom, with a prevalence of 1.0-1.5 % [95]. The incidence of CD is 
increasing over time [96-99]. CD, both undiagnosed [99], diagnosed but untreated, and 
even when treated with a gluten-free diet (GFD), is associated with a small, but 
statistically significant increased mortality [100, 101]. This is probably due to the fact 
that CD gives an increased risk of several comorbidities, such as lymfoproliferative 
malignancy, type 1 diabetes and other autoimmune diseases, as well as osteoporotic 
fractures [102]. CD was classically considered to be a childhood illness, presenting as 
malnourished children due to malabsorption, with short statue and failure to thrive. 
However, presentation of CD in adult age is now more common, and subtile and 
atypical presentations represent a substatinal clinical challenge. The majority of 
patients with CD remain undiagnosed [103, 104], and, importantly, undiagnosed adult 
patients have a reduced quality of life [105]. 
CD affects almost exclusively individuals expressing the human leukocyte antigen 
(HLA) haplotype DQ2 or DQ8, which displays an inflammatory T-cell mediated 
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immune response against gluten. These haplotypes, however, occur in about 40 % of 
the general population, so it is not sustainable as a sceening tool [106]. But a negative 
test if CD is suspected in a specific patient, will in the everyday clinical setting render 
active CD or an increased risk of developing the disease highly unlikely. CD might be 
suspected due to symptoms, to increased risk because of defined comorbidities (e.g. 
dermatitis herpetiformis, DM type 1, autoimmune thyroid disorders, Sjogrens 
syndrome) or because of familiy history of CD. However, there are cases of CD with 
negative serology, so if the clinical suspicion is high, duodenal biopsy should still be 
performed [94]. Why some of the HLA-DQ2/-DQ8 carriers develop CD, while the 
majority does not, is not fully explained, but we know that additional genetic and 
environmental factors are involved. For example, viral infections play a central role in 
CD pathogenesis [107].  
The major environmental factor responsible for the development of CD is gluten, a 
protein consisting of alcohol-soluble prolamins (which carry most of the antigenic 
properties) and insoluble gluteins [108]. The prolamine in wheat is called gliadin. CD 
patients mainly react to specific sequences in wheat gliadins, but also homologous 
sequences in rye (secalins) and barley (hordeins). In adults, a biopsy from the 
duodenum displaying architectual disturbance (e.g. villous flattening and crypt 
epithelial hyperplasia) and abnormal amount and distribution of various celltypes (e.g. 
increased number of plasma cells in the lamina propria, increased number of intra-
epithelial lymphocytes) is required for the diagnosis [94]. The degree of histologic 
pathology is graded with the Modified Marsh Classification [109]. The higher the 
Marsh score, the more serious the disease, with more pronounced symptoms, risk of 
comorbidities and morbidity. Low BMD in adult CD patients has also been found to 
be directly associated with histologic severity [110].   
The enzyme tissue transglutaminase (TG) plays a major role in the immune response 
to gluten [111]. The expression of TG increases during intestinal tissue damage, and 
can be found both in analyses of blood samples, and in intestinal biopsies in patients 
with CD. The first line screening test for CD is the IgA antibody against 
transglutaminase 2 (TG2) [94]. This is a test with a high sensitivity and specificity 
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[112, 113]. In children with positive HLA DQ-2/DQ-8 and malabsorptive symptoms, 
TG2 > 10 times upper limit is considered diagnostic, and intestinal biopsy is not 
required [114]. Spontaneous positive to negative seroconversion has been observed in 
children. This indicates that celiac autoimmunity might be transient, and subsequently, 
that serology might overestimate the prevalence of celiac disease in population based 
screening studies. However, the same phenomenon occurs very rarely in adults [104]. 
It is important to also analyze Immunoglobulin A (IgA). IgA deficiency is 10 to 15 
times more common in patients with CD than the general population, and individuals 
with IgA deficiency may have a false negative TG2 [115]. For both the duodenal 
biopsy and the serologic tests to be reliable, the patients have to be on a gluten-
containing diet. Elevated TG2 combined with Marsh score 2 or 3 is consistant with 
CD, whereas Marsh grade 0 or 1 is categorized as potential CD (and a higher risk of 
developing CD later) [94]. A commonly used model to illustrate the CD spectrum is 
the iceberg-model [116], as depicted in Figure 8.   
The visible peak above the water line represents the group with clinical manifestations 
of CD, both gastrointestinal symptoms (e.g. chronic diarrhea, abdominal pain, weight 
loss) and extra-intestinal symptoms (in adults e.g. dermatitis herpetiformis, fatigue, 
artralgia, osteoporotic fractures, neurological symptoms, infertility in women). The 
patients in the visible part of the celiac iceberg also have the characteristic histological 
changes in the small intestine, as well as elevated TG2, and they are HLA-DQ2/DQ8 
positive. The first submerged part of the iceberg represents the patients who have the 
same findings on biopsy, serology test and are HLA-DQ2/DQ8 positive, but they have 
no or minimal symptoms. The lowest part of the iceberg consists of people who share 
the same genetic markers, and have a positive TG 2, but have little or no symptoms, 
and the intestinal biopsy is normal. This status is referred to as “latent” or “potential” 






                               
Figure 8: Celiac disease iceberg model. Originally from Bozzola et al, 2014, Celiac 
Disease: An Update [116].   Design by Eir Pétursdóttir. 
 
Over the recent years, interest in the interplay between autoimmunity and bone 
metabolism has increased, and we are now aware of both direct and indirect 
interactions between antibodies and bone cells, in particular osteoclasts [117]. The role 
of TG2 in CD is one example where autoantibodies constribute to localized or 
systemic bone loss, another example is the role of anti-citrullinated protein (anti-CCP) 
in rheumatoid arthritis [118]. Even though the characteristics of the autoimmune 
disease itself (e.g. malabsorption, inflammation, immobility, glucocorticosteriod 
treatment) is perceived as the main cause of poor bone health in these patients, 
autoimmunity itself is thought to be a direct trigger. In the case of CD, the prevalence 
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of osteoporosis in newly diagnosed adult patients is significantly higher than in the 
general population, affecting up to 70 % when other comorbidities are correlated for 
[119, 120]. Malabsorption, vitamin D and calcium deficiencies are identified as the 
probable main factors leading to low BMD in CD. Patients with CD may also have a 
secondary lactose intolerance resulting from decreased lactase production by the 
damaged villi [121]. However, CD patients without signs of malabsorption also have a 
lower BMD compared to the healthy population [122]. Chronic inflammation with 
subsequent loss of integrity in the intestinal mucosal immunity, vitamin D 
insufficiency, deficiency of growth factors and increased intestinal permeability 
(“leaky gut”) are possible causes of low BMD in CD patients without evident 
malabsorption [120, 123-125].  
Furthermore, autoimmune mecahnisms, e.g. autoantibodies against osteoprotegerin 
(OPG), which inhibits bone resorption, may contribute to development of osteoporosis 
in patients with CD [117, 126]. RANKL is the key mediator for osteoclast 
proliferation, and activates RANK, stimulating the differentiation of precursors into 
mature osteoclasts with bone-resorbing activity [127]. The clinical importance of the 
OPG/RANKL/RANK system is demonstrated by the anti bone-resorptive fracture-
preventive drug denosumab, a monoclonal antibody against RANKL. Furthermore, 
TG2 itsself  belongs to a family of enzymes catalyzing a Ca2+- dependent acyl-transfer 
reaction in which new γ-amide bonds are formed, relevant to bone calcification [128]. 
This may play a direct role in modulating maturation of bone/cartilage matrix, 
facilitating the final mineralization of osteoid into bone tissue [129]. 
Osteoporosis is not the only factor leading to increased risk of fractures in adult 
patients with CD. Structural alterations of bone tissue impairing the mechanical quality 
[130, 131], reduced neuromuscular function increasing the risk of falls are also 
important aspects. There is an increased risk of fracture associated with the initial 
diagnosis of CD in adult patients [132]. Once treatment with gluten-free diet is 
initiated, the fracture risk seems to diminish [133, 134]. The younger the patient when 
starting the treatment, the better the response [135]. This indicates that early detection 
and treatment of CD is important in order to avoid fractures. The studies previously 
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performed regarding celiac disease and fracture risk are scarse, heterogenous, and 
difficult to compare [86, 132-134, 136-143]. 
Findings from cross-sectional studies suggest that low BMD and osteoporosis are 
more common in individuals with elevated anti-TG2 levels [143-145]. In a large 
retrospective study, low BMD only occurred in the CD patients with increased TG2 
levels [146]. The existing literature does not conclude whether the increased fracture 
risk in adult CD patients is substantial enough to consider a case-finding strategy, 
performing TG2 analyzes on fracture patients with no other obvious cause of fracture.  
 
1.9   Obesity and risk of fracture 
Obesity is a global epidemic, and worldwide, 44 % of adults now fulfill the diagnostic 
criteria for overweight or obesity [147]. Most of the world’s population live in 
countries where overweight and obesity kill more people than underweight and 
malnutrition. More than 1.9 billion adults were overweight in 2016, and of these, over 
650 million had obesity [147]. According to the 2020 report on global obesity from the 
World Bank Group, Norways has the fourth highest prevalence of obesity in Western-
Europe [148]. The Nord-Trøndelag Health Study (HUNT) reported an obesity 
prevalence of 23 % in 2006-2008 compared to 13 % in 1984-1986 [149]. 
Body mass index (BMI) is a simple index of weight-for-height (kg/m2), used to 
classify overweight (BMI greater than or equal to 25) and obesity (BMI greater than or 
equal to 30) in adults. High BMI is a major risk factor for premature death, 
cardiovascular diseases, diabetes, musculoskeletal disorders (especially osteoarthritis) 
and some cancers, as well as disability and reduced quality of life [147, 148], as 






                          
Figure 9: “Obesity: Health and Economic Consequences of an Impending Global 
Challenge”. Shekar, Meera and Barry Popkin, 2019. 
Washington, DC: World Bank Licence: Creative Commons Attr. CC BT 3.0 IGO. 
 
Individuals with obesity have traditionally been considered protected against 
osteoporotic fractures. A larger body mass induces greater mechanical loading on 
bone, with a consequent increase in BMD to accommodate the greater load [150]. 
Indeed, large epidemiological studies have previously shown that high BMI is 
positively correlated with increased BMD and reduced risk of fragility fractures [151]. 
However, when the mechanical loading effect is removed, both fat mass and body fat 
percentage are negatively correlated with BMD [152-154], and obesity is no longer 
considered to be protective against fractures [155]. Especially fractures at bone sites 
with a large proportion of cortical bone, such as the upper arm or ankle, are positively 
correlated with obesity [156, 157]. Fractures in individuals with obesity are asociated 
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with greater morbidity than in the general population [158]. This may be due to e.g. 
technically challenging surcial procedures, higher risk of postoperative complications, 
and a longer and more complex convalescent phase.  
It has been reported that although BMD is significantly higher in obese women with 
fractures than in their non-obese counterparts, obese women with fracture have a 
significantly lower BMD compared with women of similar age and weight without 
fractures [155]. This may lead to an underestimation of fracture probability by fracture 
algorithms such as FRAX®, since obese individuals have higher BMI and BMD [159].  
There are several potential mechanisms for affecting bone health and leading to 
increased risk of fragility fractures in obese individuals. Obesity can be considered a 
chronic inflammatory state, with increased proinflammatory cytokine production and 
insulin resistance induced by viceral fat deposits [160]. There is a higher prevalence of 
vitamin D insuffiency in individuals with obesity. However, this is likely to reflect 
greater volume of distribution of vitamin D into fat, muscle and extracellular fluid. 
Therefore, serum 25OH-vitamin D may not reflect the whole-body vitamin D status in 
obesity [158]. Other potential risk factors for osteoporotic fractures in individuals with 
high body weight are secondary hyperparathyroidism, hypogonadism, calcium 
malabsorption, comorbidities and co-medications [151].  
Obesity affects several hormones known to act on bone. For example, circulating 
levels of adiponectin are inversely related to BMD [161], and could modulate 
RANK/RANK-ligand/OPG signalling [162]. Higher serum parathyroid hormone levels 
are reported in obese individuals, which can potentially have negative effects on 
cortical bone [163]. On the other hand, we know that high subcutaneous fat mass can 
be protective against fractures, both through loading mechanisms, but also mediated 
via the aromatase expressed by adipocytes, leading to higher levels of circulating 
estradiol [158]. In addition to the effect overweight and obesity have on BMD and 
bone quality directly, there are several other factors to consider that may lead to a 
greater risk of falls with subsequent fractures. Even though individuals with 
overweight have relatively more muscle mass with possible beneficial effects [164], 
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intramuscular fat content is associated with poorer muscle function and postural 
instability, and subsequently increased risk of falls [158]. 
There is an inverse association between accumulation of body fat and decreased 
muscle mass and/or function, a fenomenon recognized as sarcopenic obesity [165]. 
Sarcopenic obesity leads to increased inflammation as part of the metabolic syndrome, 
and to impaired and altered regeneration of skeletal muscle cells. It may also be of 
relevance to distinguish between high adiposity and high BMI. A Swedish study found 
high degree of adiposity to be more common than BMI-defined obesity in elderly, and 
does not provide similar protection from osteoporosis and sarcopenia [166].  
There is a substantial overrepresentation of hyperglycemia and diabetes type 2 (DM2) 
in individuals with overweight. Both DM 2 itself and the medical treatment of DM2 
causes disturbances in the serum glucose making patients more prone to falls [167]. 
Further, greater biomechanical forces during a fall, twist or turn due to higher body 
weight, can lead to fractures at different sites compared to individuals with BMI within 
the normal range. Individuals with overweight or obesity tend to fall more backwards 
and sideways, thus e.g. the wrist is less exposed, whereas the ankle, humerus are femur 
are more exposed [155]. The ankle has little soft tissue padding, making it a vulnerable 
fracture site compared to other sites in patients with obesity.  
1.10 Case-finding to prevent fracture 
Fracture risk is multifactorial, and a broad approach is necessary to prevent as many 
fractures as possible. Even though we have extensive knowledge concerning many risk 
factors, there are still several preventable, modifiable and treatable risk factors of 
which both society and health professionals are not sufficiently aware. Understanding 
how various chronic diseases modulate fracture risk is important to both identify and 
treat people at risk. Increased knowledge will enable clinicians to perform case finding 
in a daily clinical setting on the basis of assessing individual risk factors, as well as 
health care systems to perform case finding through targeted screening programs on 
group levels where indicated. Clear guidelines with a high degree of concordance of 
recommendations would reduce confusion as to who is in need of fracture preventing 
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measures, and thereby contribute to narrowing the osteoporosis treatment gap [168]. 
Public campaigns increasing patient awareness are also very important. The patients at 
risk may appear in different clinical settings, not only in the osteoporosis clinics, but at 
their primary physician, the orthopedic ward, the gastroenterologist, or elsewhere. This 
will increase the opportunity to identify and treat modifiable risk factors for fracture 
before the fracture occurs.  
1.11 Rationale for the present study 
In order to reduce the fracture burden, there are many risk factors to consider. The 
importance of early detection and treatment of osteoporosis is recognized as an 
effective primary fracture preventing measure. Primary osteoporosis, as a result of an 
interplay between genetics, age and sex, can be treated with increased/adjusted 
exercise, optimization of diet and supplementary calcium and Vitamin D, in addition 
to effective fracture preventing medication. In secondary osteoporosis, where the cause 
of osteoporosis is another medical condition or medication, it is essential to treat the 
disease responsible for the reduced bone quality, in order to limit its negative effect on 
bone. The earlier the condition causing osteoporosis is diagnosed and treatment 
initiated, the better the fracture preventing effect will be. However, most fractures 
occur in people without osteoporosis, and fracture etiology comprises so much more. 
Fracture preventing case finding strategies needs to look beyond the BMD-values, and 
fracture prediction tools like FRAX® do not take into account all relevant risk factors.  
With this background, the aim of the current study was to better assess risk of fracture 
in daily clinical practice in three chosen settings where official guidelines are lacking 
or not agreed upon: 
1)  Patients with CD 
2)  Individuals with overweight or obesity  
3)  Radiologically defined fracture subgroups  
We looked at two different peripheral fracture types. Distal radius fractures, which we 
know are closely related to osteoporosis, and ankle fractures. Ankle fractures were 
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chosen because the literature was inconclusive on ethiology and the high prevalence. 
We also wanted to compare and study the contrast between these two types of 
fractures.  
The Norwegian authorities have stated that research is one of the main tasks of public 
hospitals, and that all health trusts in Norway are obligated to do research alongside 
patient care. Establishing strong research environments can be a challenge for small 
health trusts and hospitals, with limited resources both financially and when it comes 
to research support systems, as well as having few specialized physicians within the 
same profession. At the same time, we also found these same challenges to be 
advantages. The treatment of patients and the clinical research go hand in hand, the 
number of medical professionals involved are few, making the system effective and 
reliable. Cooperation between different professions is easy to achieve, because of 
compact personnel groups and the clinicians being used to working with a wide range 
of medical issues and challenges. We wanted to strengthen the research network in 
Helse Førde, and build an extensive database and biobank for multi-purpose use. We 
designed the database with the potential of later national and international 
collaboration in mind, and wanted to collect data comparable to studies performed 
elsewhere in Norway.  
Sogn & Fjordane county (from January 2020 part of Vestland county) is an interesting 
region in which to perform patient oriented clinical research. In the mid-1970s, Sogn 
& Fjordane was included in the National Health Screening Service due to its favorable 
characteristics with respect to cardiovascular morbidity, life expectancy and health 
behaviors. The county spans an area of 18,623 km2, holds approximately 110,000 







 Sogn & Fjordane, Helse Førde institutions 
In Norway, Sogn & Fjordane has had the longest-lived population for decades. The 
lifestyle of the population has been characterized by moderation and adherence to 
traditional values, and the divorce rate, consumption of alcohol, prevalence of daily 
smoking and crime rate have been low compared to other regions of Norway [169]. 
And even though the regional differences within the country seem to diminish over 
time [170, 171], still, life expectancy at birth was in 2002-2016 found to be 0.6 years 
longer in Sogn & Fjordane than in Norway in general for men, and 1.2 years longer for 
women [172].  
Higher rates of hip fracture and all fractures combined have been observed in urban 
compared to rural areas in Norway [173]. Studies by Omsland et al have shown 
differences in hip and forearm BMD measurements in rural compared to urban areas, 
and urban women have an increased risk of forearm fractures compared to rural 
women [174, 175]. This research originates from NOREPOS (The Norwegian 
Epidemiologic Osteoporosis Studies [176], sub studies within large population-based 
surveys in four districts in Norway (Tromsø, Nord-Trøndelag, Hordaland and Oslo), 
which are also linked to big epidemiological research groups in Scandinavia. The 
collaboration with NOREPOS has been a source of expertise to lean on, and allowed 
us to develop our own team with quality and assurance, and to expand our national and 
international network.  
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2 AIMS 
Overall, this dissertation sought to explore risk factors for peripheral fractures in 
adults, in order to improve target case-finding strategies in daily clinical practice as a 
fracture prevention measure.   
The specific aims were: 
Paper I:  
1) To summarize existing knowledge concerning the risk of fracture in adult 
patients with celiac disease (CD) 
2) To provide clinicians with increased knowledge on how to evaluate the 
potential risk of fracture in CD-patients, and which patients should be 
referred to DXA scan 
Paper II:  
1)   To investigate the prevalence of positive TG2 and celiac disease in patients 
with distal radius or ankle fracture compared to community based controls, 
in order to see if patients with peripheral fractures had greater odds of CD 
compared to healthy controls  
2)  To advice clinicians about whether fracture patients ought to be screened for 
suspected CD 
Paper III:  
1) To determine whether radiographic complexity using the A0-classification 
of distal radius fractures can be indicative of osteoporosis 
2) To prove or disprove if the radiographic severity of distal radius fracture can 
be used by the clinician to decide which patients should be referred for 
fracture risk assessment and/or treatment to prevent secondary fractures  
Paper IV:  
1) To investigate associations of overweight, obesity and osteoporosis with 
ankle fractures compared to controls without previous fractures  
2) To investigate associations of overweight, obesity and osteoporosis with 





3 MATERIALS AND METHODS 
3.1 Study design 
The FABB-study (“Forekomst Av Beinskjørhet og Blodprøvemarkør på cøliaki hos 
pasienter med distalt radius- og ankelbrudd i Sogn og Fjordane”) is a case-control 
study designed with the main objective to investigate whether adult patients suffering a 
distal radius or ankle fracture had a greater prevalence of celiac disease compared to 
healthy controls. To our knowledge, no previous case control studies with this aim 
have been conducted. The main exposure was known or undiagnosed CD (with 
positive TG2 as the marker), and the main outcome was the occurrence of fracture of 
the distal radius or ankle. The sample size was calculated during the study planning 
phase using a conventional test for difference in proportions. We assumed a CD 
prevalence of approximately 1 % in the control group and 3-5 % in the case group, 
according to the best available estimates [95, 120]. However, during enrollment, we 
needed to adjust to the daily clinical setting and available resources, and make sure 
that our osteoporosis clinic could manage the inclusion of study patients without this 
affecting standard patient care. Having patients with distal radius fractures referred to 
DXA-scanning was indicated also according to current secondary fracture preventing 
guidelines. We therefore aimed to include participants with a 2:1 ratio of cases and 
controls (400 patients and 200 controls), thus yielding the FABB-study underpowered 
to conclude in some aspects.  However, the research questions we aimed to address 
with this study also consisted of several other factors, affecting the final design.  
Starting from January 2012, after a 6 months planning phase, we had several 
information meetings with physicians, nurses and health secretaries at the orthopedic 
departments in The Helse Førde Trust, both at Førde Central Hospital, as well as the 
hospitals in Nordfjordeid and Lærdal. We wanted to ensure that the recruitment of 
fracture patients was evenly distributed from all the municipalities, in the same manner 
as the planned community-based controls would be. There were posters with 
information in the relevant waiting areas (Appendix 1), and nurses and secretaries 
helped to remind new interns and physicians to ask patients if they wanted to 
participate in the study.   
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3.2 Study population and participation rates 
3.2.1 Cases 
From March 1, 2012 until January 13, 2017, 400 consecutive patients age 40 or 
older permanently living in Sogn & Fjordane county with an acute distal radius 
fracture or ankle fracture were referred to the rheumatology outpatient clinic, after 
being asked to participate by physicians at the orthopedic departments (Table 1).  
Inclusion criteria Exclusion criteria 
≥ 40 years of age 
Recent fracture of  
a) Distal radius 
b) Ankle (all involving the lateral 
malleolus, including those 
affecting the medial malleolus) 
Able to give informed consent 
< 40 years of age 
Trimalleolar fracture 
Not able to give informed 
consent 
 
     Table 1: Inclusion and exclusion criteria for the fracture patients. 
The ankle fractures had to involve the lateral malleolus. Trimalleolar ankle 
fractures were not included because of an assumed higher likelihood of high-
energy trauma, including traffic accidents. We included both patients with low 
energy fractures (equivalent to a fall from standing height or lower) and fractures 
due to traumas with higher energy. The majority of patients were invited to 
participate in the study at the first contact with the orthopedic outpatients clinic, 
others at later planned controls or at the time of planned day surgery of the fracture. 
Still, after the first year of inclusion, we discovered that some patients who were 
eligible for participation had not been asked, resulting in a revision of the 
procedure. In addition to the existing referral system, the head of the orthopedic 
department delegated to two orthopedic interns to go through lists of patients with 
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the relevant ICD-10 codes, to make sure that all those eligible to participate in the 
study, were in fact asked. If this was not mentioned in the patients’ medical charts, 
the intern called and asked the patient if he or she had been previously informed 
about the study, and, if not, if they wanted to participate. This was done on a 
monthly basis. If the patient wanted to participate, he or she was referred to the 
rheumatology department. We then sent a letter with detailed information about the 
study (Appendix 2), two copies of the consent form (Appendix 4), and the 
questionnaire (Appendix 6). In this letter, the patient was informed that he/she 
would receive an appointment at the rheumatology outpatient clinic at Førde 
Central Hospital within 4-8 weeks. We aimed to coordinate the appointment with a 
planned follow up visit at the orthopedic outpatient clinic, to avoid excess travel for 
the patient.  
3.2.2 Controls 
We requested the Norwegian Population Registry to identify controls. After having 
included approximately 100 fracture patients, we asked for lists of randomly 
selected controls from all municipalities in Sogn & Fjordane, in the following age 
cathegories: 40-49 years, 50-59 years, 60-69 years, 70-79 years and 80 years and 
older, asking for 2/3 women and 1/3 men, and double the numbers we aimed to 
include in the study, e.g 200. As planned, we later asked for a second withdraw, at 
a time when we were then able to adjust according to the age- and sex-distribution 
of cases so far included.  
Inclusion criteria Exclusion criteria 
≥ 40 years of age 
Able to give informed consent 
Not able to give informed consent 
Previous fracture (except fingers or 
toes) 
       Table 2: Inclusion and exclusion criteria for the controls. 
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We mailed a letter with detailed information about the study (Appendix 3), two 
copies of the consent form (Appendix 4), and the questionnaire (Appendix 6). In 
this letter, the individual was informed that he/she would receive a notice with an 
appointment at the rheumatology outpatient clinic at Førde Central Hospital within 
4-8 weeks. Despite information given on previous fractures being an exclusion 
criteria, some of the controls who accepted the invitation turned out to have had 
previous fractures, and could not be included. If these persons wanted, they were 
still examined with DXA-scan and received appropriate follow up, but were not 
enrolled in the study. For the controls, all examinations were free of charge. The 
controls were included during the same time period as the cases to best assure true 
comparability of the DXA-results and serum analyzes. 
3.2.3 Participation rate 
In order to include 400 fracture patients in the study, 780 consecutive fracture 
patients fulfilling the inclusion criteria were invited to participate, yielding a 
participation rate of 51.3 %. This consisted of 289 included patients with distal 
radius fracture (516 asked, 56.0 % participation rate) and 108 patients with ankle 
fracture (264 asked, 40.9 % participation rate). We included 199 controls (the 
protocol aimed for 200 controls), out of 467 invited (42.6%).  
3.2.4 Study outline/flow chart 
The study outline, inclusion and the different subgroups of study participants who 
are included in each of Papers II, III and IV are illustrated in the flow chart 
presented in Figure 11. In Paper II, the 400 primarily included fracture patients are 
compared to the controls. Two of the 199 controls had stated in the questionnaire 
using gluten free diet, despite not having celiac disease. This could potentially 
result in a false negative TG2, and these two controls were therefore excluded. In 
Paper III, five of the 289 distal radius fracture patients could not be assessed when 
it came to fracture severity, because of the radiographic images not being 





Figure 11: FABB-study Flow Chart 
In the process of systematically reanalyzing all x-rays, we discovered patients who 
had been registered in the database with incorrect information. In the case of the 
distal radius fracture group, two were misclassified as fractures (these were sprains 
with no visible fracture line). One patients was registered as a distal radius fracture, 
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but was in fact a proximal radius fracture of the elbow joint. Three ankle fractures 
had been registered as distal radius fractures but were ankle fracture patients, and 
one trimalleolar fracture had been included, even though this was an exclusion 
criteria. In addition to this, one patient was primarily registered as having both a 
distal radius fracture and an ankle fracture in the same trauma, however, this ankle 
fracture was in fact an isolated medial malleolus fracture, and was therefore later 
exluded from sub analysis. 
3.3 Data collection 
On the day of examination, the patient or control met one of the two physicians in 
charge of the study. Information concerning consent, exclusion and inclusion 
criteria was repeated, and, if the criteria were fulfilled and the patient still wanted 
to participate, a study number was provided, and the consent form was signed in 
two copies by both patient/control and physician. The DXA scanning was then 
performed, and height and weight were measured. A blood sample was obtained 
and analyzed, and serum and full blood samples were stored in biobank. After 
these procedures were completed, the patient or control had a consultation with the 
physician, where the results of the DXA scan and the patient/control questionnaire 
was reviewed. Appropriate measures to prevent further fracture, or in the case of 
the healthy controls, primary fracture prevention, was either initiated, or 
recommended to the participants’ general practitioner. Some results of the serum 
analysis performed and corresponding medical advice was sent to the patient and 
general practitioner 1-2 weeks after the examination day, because the analysis were 
performed elsewhere (described in section 3.3.3). 
3.3.1 Questionnaire 
The participants answered a self-administered questionnaire in the time interval 
between receiving this by letter, and at the latest, at the day of inclusion. The 
questions concerned parental and maternal history of fractures, number and 
fracture history of siblings, diagnosed celiac disease of the participant or first 
degree relatives, daily intake of milk and cheese, use of vitamin supplements, 
 47
hereunder specified calcium, vitamin D and/or omega 3 supplements, the trauma 
mechanism and month of fracture, age and localization of previous fractures (the 
questions regarding fractures were removed from the controls’ version of the 
questionnaire), physical activity using the modified IPAQ (International Physical 
Activity Questionnaire) score, comorbidities, use of gluten-free diet, diagnosed 
dermatitis herpetiformis, performed duodenal biopsy, daily medication, historic use 
of glucocorticoids for more than 3 months, current and previous use of tobacco and 
alcohol, questions regarding abdominal symptoms, and questions concerning age 
of menarche and menopause, and miscarriages (women) (Appendix 6). 
3.3.2 BMD 
Height (m) and weight (kg) were measured in light clothing without shoes before 
the DXA examination. BMD was then measured at the femoral neck and total hip 
at both sides and at the lumbar spine (L1-L4), using GE Healthcare Lunar Prodigy 
Rtg 5603, manufacture year 2000, with a daily quality assurance of +/- 2 %. The 
procedure was performed with the participant lying straight on the back. When 
measuring the lumbar spine, the patient was positioned with the knees in a 90 
degree angle using a pillow under the calfs. The hips were measured with the 
femora straight on the table and rotated 15-25 % inwards, achieved by a spacer 
placed between the ankles. BMD T-scores were calculated using US National 
Health and Nutrition Examination Survey (NHANES III) reference population of 
female Caucasians aged 20-29 years for femoral neck and total hip [177] and Lunar 
female reference database for lumbar spine. 
3.3.3 Laboratory tests 
Serum analyses to reveal possible causes of secondary osteoporosis and increased 
fracture risk were performed, including white blood cell count, hemoglobin, 
sedimentation rate, serum electrophoresis, ionized calcium, albumin, thyroid-
stimulating hormone, parathyroid hormone, 25-OH Vitamin D, alkaline 
phosphatase, alaninaminotranferase, aspartataminotransferase, ferritin, folic acid, 
total Ig A and, deaminated gliadin and TG2. TG2 was in 52.1% analyzed with an 
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ELISA test, 5.7 % by an EliA method (Unicap 100 by Phadia®) and in the 
remaining 42.2 % by a multiplex flow immunoassay (BioPlex® 2200 Celiac IgA). 
In addition, in men analyses also included testosterone, lutenising hormone (LH) 
and follicle-stimulating hormone (FSH). LH and FSH were analyzed using 
Immulite 2000XpI (Siemens®). TG2, demaminated gliadin and the sex hormone 
analyses were performed at laboratories at Haukeland University Hospital in 
Bergen. 25 OH-Vitamin D was for the first two thirds of the inclusion period 
measured at Haukeland University Hospital, but shifted to Førde Central Hospital 
when the laboratory there started to perform these analyses. The remaining serum 
samples were analyzed by the laboratory in Førde Central Hospital.  
3.3.4 Radiological examinations 
The radiological examinations were performed at one of the three radiologic 
departments in Helse Førde, located in Førde, Nordfjordeid and Lærdal, according 
to standard clinical procedure. The examinations were performed with FUJI® XG-
1, Simens Luminos Fluorospot Compact FD and GE Healthcare Discovery XR656 
(Førde), FUJI® XG-1, detector Canon® CXDI 50 G (Nordfjordeid), FUJI® XG-1, 
detector Canon® CXDI (Decotron) (Lærdal). The radiographic ankle series 
included anteroposterior, mortise (with the foot in 10 degrees internal rotation) and 
lateral radiographs. The distal radius series images comprised standard 
anterioposterior and lateral radiographs. In September through November 2019, 
one experienced radiologist reviewed all the x-rays, and classified the ankle 
fractures according to the Danis-Weber classification and the number of uni- and 
bimalleolar involvement, and the distal radius fractures according to the AO-
classification. In 197 of 289 distal radius fracture patients included (68%), there 
were additional CT scans available, and these were also reviewed and used as 




3.4 Statistical analyses 
3.4.1 Paper II 
Continuous data are described as means and percentages. Associations between 
categorical variables were calculated using Pearson’s chi square test. Associations 
between CD and fracture are presented in terms of odds ratios (ORs) with 95 % 
confidence intervals, estimated from logistic regression models. All analyses were 
performed using IBM® SPSS Statistics version 24, 2016 and R (version 3.4.1 for 
Mac OS). All p values are two-sided, and values < 0.5 are considered statistically 
significant.  
3.4.2 Paper III 
Descriptive statistics for age, sex, BMI, number of patients with 
osteoporosis/osteopenia/normal BMD, and overweight were performed in the distal 
fracture group. Data between subgroups were compared using chi square or 
Fisher’s exact test for categorical data and two-sample t-test or Mann-Whitney U 
test for continuous data. ORs were estimated with 95% confidence intervals using 
unconditional logistic regression models. All p-values are two-sided and values 
below 0.05 are considered statistically significant. All calculations were performed 
using R version 3.6.2. 
3.4.3 Paper IV 
Descriptive statistics for age, sex, height, BMI, osteoporosis, osteopenia, smoking, 
physical activity, low energy trauma (yes/no), 25-(OH) vitamin D levels and 
polypharmacy were performed. Data for fracture patients were compared with 
controls using chi square or Fisher’s exact test for categorical data and two-sample 
t-test or Mann-Whitney U test for continuous data. ORs were estimated with 95% 
confidence intervals using unconditional logistic regression models. All p-values 
were two-sided, and values below 0.05 were considered statistically significant. All 
calculations were performed using R version 3.6.2. 
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3.5 Ethical conciderations 
The study protocol was approved by the Regional Committee for Medical and Health 
Research Ethics (REC West) (Appendix 7). All participants signed a written informed 
consent form on the day of examination. 
All referred fracture patients were recommended to have the DXA scan performed if 
considered clinically indicated, regardless of participation in the study. Advice on 
dietary supplements, recommendation on treatment with bone-sparing agents like 
antiresorptives, and advice concerning the indication for a DXA follow up was given 
to the participants and their primary physician. In the case of positive laboratory tests, 
e.g. serum electrophoresis with M component or hypercalcemia, the patients were 
referred to the corresponding specialist (a hematologist or endocrinologist). Patients 
with positive TG2 were, after being asked if they wanted further examination, referred 
to the gastroenterology department. All except two participants with positive TG2 had 
a duodenal biopsy taken, after discussion with the consulting gastroenterologist. This 
was not part of our study, but standard clinical follow up care.  
The screening of fracture patients for CD raises important ethical issues. Universal 
screening of fracture patients is not recommended, since the prevalence of CD in 
patients with a recent fracture is unknown, and subsequently, also the cost-benefit of 
such screening. A study from The Netherlands published in 2020 was the first study 
where patients at a fracture liaison service (FLS) were systematically screened for CD 
[178]. The prevalence of CD in this cohort of fracture patients was 0.38 %, and the 
authors do not recommend standard screening for CD in FLS patients. This knowledge 
was not available at the time when our study protocol was being designed. The 
prevalence of CD also varies within Europe, being higher in Scandinavian countries. 
Systematic prevalence studies in Norway have yet to be performed. A positive TG2 in 
adults usually leads to the recommendation of further examination with upper 
endoscopy and duodenal biopsy. The complication rates of upper endoscopy is low, 
and if complications occur, are most often associated with sedation [179]. Still, 
however small, as with all procedures, there is a potential risk of serious 
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complications, e.g. perforation of the esophagus or ventricle. This potential risk must 
be weighed against the potential benefit of being diagnosed with CD. It has been 
shown, that even adult and elderly patients with no subjective complaints before 
diagnosis, reported a better quality of life after starting treatment with gluten free diet 
[105]. This may be explained by the variety of both common constitutional and 
gastrointestinal symptoms that untreated CD may express, and such symptoms can 
easily be accepted by the patient as common complaints and “part of life”. In addition, 
as discussed in section 1.8, the fact that patients with untreated CD have an increased 
mortality, indicates a potential benefit of targeted screening in groups of people with a 
perceived higher risk of CD compared to the general population.   
Consideration of screening for osteoporosis in postmenopausal women and elderly 
men with distal radius fractures is recommended, in order to prevent secondary 
fractures [180-182]. When it comes to ankle fractures, there are no guidelines for 
referral to DXA scan evaluation. But, the DXA emits very limited doses of x-rays, and 
does not pose any risk to the participants. It is pain-free, and non-invasive. Still, if 
ankle fractures are not in fact related to osteoporosis, and do not increase the patients’ 
risk of a later major osteoporotic fracture, it is not ethical to use health resources for 
this purpose in clinical practice.  
Regarding the ankle fracture patients and the control groups, many cases of 
osteoporosis were revealed, that would have remained undiagnosed, if not for the 
study participation. This is an ethical dilemma, providing information to the patient on 
increased fracture risk, and perhaps recommending treatment to decrease this risk, 
when the patient might, in retrospect, have preferred not knowing. However, in our 
daily clinical settings, patients usually appreciate the opportunity to prevent a potential 





4.    MAIN RESULTS  
4.1 Paper I  
Celiac disease and risk of fracture in adults- a review. 
We identified eleven relevant original studies published in 2000-2011, where celiac 
disease was the exposure and fracture the outcome, ten being cross-sectional studies 
[132-134, 136-142] and one being a case study [183]. The results of the analyzed 
articles are summed up in Figure 12, here also included a metanalysis by Olmos et al 
[86], including all but three of the papers we include in our review. 
Figure 12: Illustration on reviewed literature in Paper I. 
The x-axis shows the Risk Ratio (Vestergaard and Mosekilde), Hazard Ratio (Sanches et al, Ludvigsson et al and 
West et al) or Odds ratio (all other studied referred) with 95 % confidence intervals. The studies not weighted, 
and no metaanalysis has been performed. 
The included studies were heterogeneous, differing both in design, selection criteria, 
sample size and the CD entity, and were subsequently challenging to compare. 
However, the overall findings indicate a positive association between CD and risk of 
fracture. On the basis of this literature review, we recommended that adult patients 
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with CD should be referred to bone densitometry for assessment of osteoporosis and 
evaluation of fracture risk. 
4.2 Paper II 
Positive IgA against transglutaminase 2 in patients with distal radius and ankle 
fractures compared to community-based controls. 
Twelve participants (10 fracture patients and two controls) had positive TG2, among 
whom seven had osteoporosis, and the remaining osteopenia. About 2.5 % of the 400 
fracture patients had positive TG2, compared to 1 % of the 197 community-based 
controls, giving an odds ratio of 2.5 for having positive TG2. This difference is not 
statistically significant, but there is a trend towards positive TG2 being more prevalent 
in fracture patients than in controls. This supports recommended clinical practice in 
Norway, which is to be aware of the fact that CD can cause secondary osteoporosis 
and fractures, and examine patients with CD-serology tests upon suspicion.  
The prevalence of osteoporosis was significantly higher in the distal radius fracture 
group than in the healthy controls and ankle fracture patients. 
4.3 Paper III  
No association between osteoporosis and AO classification of distal radius 
fractures: an observational study of 289 patients. 
Of 289 distal radius fracture patients aged ≥ 40 years, both male and female, 130 had 
osteoporosis. The patients with osteoporosis did not have increased odds of a more 
complex distal radius fracture (defined as AO-classification fracture types B or C 
compared to type A fractures) compared to patients with osteopenia or normal BMD. 
Current smoking and a low energy trauma mechanism were associated with less 
complex fractures (Type A). We concluded that the AO-classification of distal radius 
fractures cannot be used to decide which patients should be referred to DXA scan and 
considered for secondary fracture prevention.  
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4.4 Paper IV 
Associations of overweight, obesity and osteoporosis with ankle fractures. 
We investigated 108 patients with ankle fractures and compared them to 199 
community-based controls without a fracture history. In addition, we investigated the 
associations of overweight, obesity and osteoporosis with lateral malleolus fracture 
subgroups according to the Danis-Weber (D-W) classification system.  
Overweight increased the odds of ankle fractures and the odds of sustaining an ankle 
fracture with possible instability (D-W type B or C) compared to the more stable D-W 
type A fracture. Osteoporosis did not significantly increase the odds of ankle fractures. 
We conclude that having suffered an ankle fracture does not automatically indicate the 
need of further osteoporosis assessment.  
 





5.    DISCUSSION  
5.1 CD and TG2 in patients with fracture 
In paper II, we compared individuals with known CD and positive TG2 among the 
fracture patients to the controls with no fracture history. The subjects with known 
biopsy verified CD before entering the study, all had negative TG2, indicating 
compliant treatment to gluten-free diet. In total, 6 subjects with known CD and 12 with 
positive TG2 participated in the study.  
 
Table 3: Overview of CD and TG2 positive subjects in the study. 
C: controls, P: patients 
We did not find any statistically significant difference in the prevalence of CD 
(diagnosed and undiagnosed) in patients with fractures compared to controls. The 
statistical power of the study is, however, not sufficient in order to rule out such an 
association, as discussed in sections 3.1 and 6.4. The results nevertheless indicate that 
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positive TG2 is more commonly found in fracture patients than in controls. Larger, 
population-based prospective studies are needed in order to assess if positive TG2 
increases the risk of fracture. 
As discussed in section 1.8, osteoporosis is considered the main risk factor for the 
increased fracture risk in CD-patients. In addition, several BMD-independent variables 
leading to increased risk, such as reduced bone quality, changes in fat and muscle 
composition, Vitamin D insufficiency, increased risk of falls and other associated 
autoimmune diseases and their treatment, should also be considered. Most fractures in 
CD patients seem to occur before the CD diagnosis is made, and in patients who are 
non-compliant to the gluten-free diet (GFD) [133, 135]. There is a marked and fast 
reduction in fracture risk after transition to GFD when diagnosed with CD, already 
statistically significant after a year [184]. This could indicate that factors other than 
BMD are relevant for the increased fracture risk in CD-patients, the improvement in 
BMD being a slow process, unless potent pharmaceutical agents are in play. On the 
other hand, studies have shown significantly increased T-scores as soon as 2 years 
after starting GFD [143]. Also, a recent registry-based cohort study found that if a CD 
patient underwent a DXA scan, and the result was included in the FRAX® calculation, 
CD was no longer a significant risk factor for fracture. When the authors defined CD 
as a secondary osteoporosis risk factor in FRAX, the same conclusion was made [185]. 
However, in their analyses, all fractures associated with a trauma diagnosis code were 
excluded and the control group were selected from patients who did not fulfill the 
criteria for CD. This raises the concern whether all relevant fractures were actually 
taken into consideration here, or if the fracture prevalence and the spectrum of fracture 
risk in CD patients were underestimated.  
We do not suggest that all patients with fracture should be screened for CD, as the pre-
test likelihood of CD is too small for this to be recommended [94]. We do, however, 
think that the current threshold for screening upon clinical suspicion should be 
lowered, at least in countries with a high prevalence of CD. It has been shown, that in 
addition to significantly reducing the fracture risk after CD has been diagnosed and 
treatment been initiated, the risk of malignancies is reduced [102] and the quality of 
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life, even in the elderly, is improved [105]. And the earlier the diagnosis is made, the 
better the response of initiation of treatment and long-term outcome, both concerning 
intestinal and extra-intestinal manifestations. The close relationship between CD and 
other autoimmune diseases has also led to a new research field exploring whether early 
GDF in TG2 positive individuals, can in fact prevent CD from becoming clinically 
apparent, and may delay, or prevent, other autoimmune diseases from arising (e.g. type 
1 diabetes and thyroid disease) [186].  
 
5.2 Osteoporosis as a risk factor for distal radius and ankle fractures 
It is well known that distal radius fractures in adults are closely related to low bone 
mineral density [9], and that patients sustaining a distal radius fracture have an 
increased risk of a major osteoporotic fracture later in life [70]. Results of our study 
also supports such an association, finding that the prevalence of osteoporosis was 
significantly higher in the radius fracture group (45.0 %) than in the ankle fracture 
patients (23.2 %) and control group (22.3%) (p<0.001). The results were also 
significant when adjusted for sex and age.   
The patients with distal radius fractures and osteoporosis had, compared to those with 
osteopenia or normal BMD values, a statistically lower BMI, they were older, a higher 
percentage were women, and there were more current smokers. There was also a 
significantly higher proportion of low energy trauma causative of the distal radius 
fracture in the patients with osteoporosis by DXA measurement. All these factors are 
in line with the notion that distal radius fracture are associated with the same risk 
factors that we recognize as classical risk factors for osteoporosis. This stands in 
contrast to the ankle fracture patients, in which the prevalence of osteoporosis was 
comparable to that in the control group, and osteoporosis did not significantly increase 
the odds of ankle fracture in our study (crude OR 1.03 (95 % CI 0.58-1.79), adjusted 
for age and sex OR 1.31 (0.72-2.38), adjusted for age, sex, BMI and smoking status 
OR 1.65 (0.86-3.14)). Furthermore, there were no significant differences by sex, 
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smoking habits or trauma mechanism comparing the patients with ankle fracture and 
osteoporosis to the ankle fracture patients with osteopenia or normal BMD (Table 4).  
 
Table 4: Characteristics of patients with and without osteoporosis in the ankle- and 
distal radius fracture groups.  
Two sample t-test is used for continuous data (BMI), Chi-squared test or Fishers exact test for count data when 
applicable. 
 
Results of our study confirm that distal radius fractures are closely related to 
osteoporosis while ankle fractures are not. Having sustained an ankle fracture, even 








5.3 Risk factors for ankle fracture  
Ankle fractures were included as one of the two fracture types in our study, partly 
based on the high prevalence, partly on the fact that previous epidemiological studies 
had found varying results regarding risk factors for ankle fractures, and whether they 
are associated with osteoporosis or not. As discussed in Paper IV and section 1.6, 
some studies have been performed, but these are heterogenous and difficult to 
compare. Some of these studies conclude that low BMD is a risk factor for ankle 
fracture [187-189], others find no such correlation [190-193]. Being overweight or 
obese has been identified as a risk factor in several studies [75, 78, 79, 160, 187, 192, 
194], most of these include postmenopausal and older women. Other risk factors 
discussed are age, sex, smoking, level of physical activity, previous fractures or falls, 
diabetes, polypharmacy, deteriorated bone architecture and trabecular bone score 
(TBS). In our study, we included 108 ankle fractures, with a mean age of 57.4 years, 
and 77% women. Older age gave lower odds of fracture. One possible explanation for 
this could be a lower degree of vigorous physical and sports activities with older age. 
However, the level of activity as assessed by the IPAQ did not significantly differ 
between the ankle fracture patients and controls without a fracture history. We might 
speculate that the elderly sustain different peripheral fractures in the case of a fall, 
because of different biomechanical factors at play. Daily use of three or more 
prescribed drugs gave an adjusted OR of 1.40 for ankle fracture, but the result was not 
significant. Male sex was a significant risk factor for ankle fracture, the opposite result 
as would be expected with an osteoporosis-related fracture type. The results from our 







Figure 13: Risk factors for ankle fracture. 
The figure shows multivariable odds ratios (ORs) with 95 % CIs for different risk factors comparing ankle 
fractures to controls, adjusted for all examined variables.      * Per 5 BMI units. Whiskers represent 95 % 
confidence intervals. 
 
5.4 Osteoporosis and the AO classification of distal radius fractures 
In the osteoporosis outpatient clinic where the study was conducted, patients are 
referred to DXA scanning from both orthopedic surgeons and primary care physicians. 
Reading referrals, there seemed to us to be a clinical assumption that the more 
complex or severe the peripheral fracture, the higher the likelihood of osteoporosis. 
However, searching the literature for studies examining this topic, there were few to be 
found [195-199]. In our study, patients with osteoporosis did not have increased odds 
of a more complex distal radius fracture, defined as AO type B and C, versus type A 
(OR 1.11, 95 % CI 0.52-2.33), when compared to those with osteopenia or normal 
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BMD. Type B fractures had a higher mean BMD than type A and C (Figure 14), and 
also had a higher mean BMI. A higher percentage with type B fractures were male 
compared to type A and C.  
 
 
Figure 14: Box plot illustrating left hip BMD in different AO subgroups. 
Centre horizontal line of the boxes represents the median. The boxes contain Q1 (25th Percentile) to Q3 (75th 
Percentile). IQR (Interquartile range) is the distance between Q1 and Q3. The bottom whiskers: less than Q1 – 
1.5*IQR. The upper whiskers: greater than Q3 + 1.5*IQR. 
 
Low energy trauma was associated with less complex fractures (type A). And, even 
though not statistically different, there is a trend towards a higher mean BMD in 
patients with distal radius fractures regarded as most severe (type C) compared to the 
less severe type A. A similar result was found in the study by Clayton et al [197]. As 
we stated in Paper III, the AO classification system does not fully capture the 
complexity and severity of distal radius fractures. Studies have found an association 
between low BMD and other radiographic deformities, such as ulnar variance, radial 
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inclination and dorsal angulation [200]. The thickness of cortical bone is greater in the 
metaphyseal area compared to the epiphyseal/intra-articular area. It may therefore be 
mechanically plausible that patients with osteoporosis, e.g. with reduced cortical 
thickness, would fracture easier in the methaphyseal area, and therefore suffer a type A 
fracture instead of a intraarticular type B or C fracture [198]. Xie et al [195] looked at 
the contralateral non-fractured radius in 70 women with recent distal radius fractures, 
and found that the mean cortical thickness was lower in displaced compared to non-
displaced fractures, supporting this theory. Dhainut et al [199], assessing 110 female 
patients with fragility fractures of the distal radius, hypothesize that severity of such a 
fracture is more associated with bone quality parameters, rather than BMD. Their 
theory is supported by a study that found reduced bone material strength as measured 
by impact microindentation in patients with distal radius fractures compared to non-
fracture controls [201]. Another interesting theory to consider is that people who have 
been diagnosed with osteoporosis may behave differently because of fear of falling 
and the awareness of an increased fracture risk, perhaps avoiding certain activities. 
 
5.5 Overweight and the D-W classification of ankle fractures 
Of the 108 patients with ankle fractures and available radiographic imaging, 17 
patients had a type A fracture, 71 type B, and 20 a type C fracture according to the D-
W classification system. There were clear differences in the prevalence of overweight 
and obesity between D-W subgroups, the most striking being 38.0 and 40.0 % of 
individuals with obesity in D-W type B and C, respectively, compared to 17.7 % in the 
patients with D-W type A fracture. The prevalence of overweight and obesity, as well 
as mean BMI, in ankle fracture patients, fracture subgroups and controls is illustrated 







Table 5: Age, sex, and prevalence of overweight and obesity in ankle fractures, ankle 
fracture D-W subgroups and controls. 
 
The median BMI in the type A group was 25.3, compared to 28.4 in the combined D-
W type B or C fracture group, a result that was statistically significant. In Paper IV, we 
report that patients with overweight had a significantly higher odds of having a B or C 
fracture compared to type A. Considering that high body weight adds to the force in a 
fall or an ankle sprain, this does not come as a surprise. Even though the trauma 
mechanism was per definition a low energy trauma in approximately 70 % of cases, a 
high body weight increases the strain on the bone structures, and what seems like a 
small trauma, can lead to a serious injury. The fact that individuals with a high body 
weight seem to have a predisposition to fall sideways or backwards instead of 
forwards [202], may also be significant in the resulting fracture type. There are 
however, methodological issues that require mentioning, as are also briefly discussed 
in paper IV. We chose to combine the D-W types B and C into one group in our 
statistical analyses, since both these fracture subtypes are at risk of syndesmosis 
disruption, and subsequently, instability of the fracture [81]. The type B fracture is 
sometimes stable, sometimes unstable, and more diagnostic testing is often required to 
establish the need for surgical intervention. In order to assess the stability of the 
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syndesmosis and deltoid ligament, being essential for ankle joint stability, stress 
radiographs are recommended in addition to the clinical assessment by the orthopedic 
surgeon [203]. However, D-W type B and type C are known to differ in trauma 
mechanism, type B usually caused by a combination of supination and external 
rotation of the ankle joint, compared to type C more often caused by a pronation-
abduction trauma [204]. These differences in trauma mechanisms are the basis of 
another classification system of ankle fractures, the Lauge-Hansen classification. 
Including this in our study might have added to the clinical relevance of our results. 
However, our results are in line with the study by King et al [205], increasing the 
probability that we have in fact been able to demonstrate a true association. Their 
study was a retrospective review of 280 patients with ankle fractures, using a 
multivariate cumulative logit model to assess the relationship between obesity and the 
D-W classification. They concluded that patients with a BMI of 30 kg/m2 or greater 
had an OR of 1.78 of having a D-W C fracture compared to types A and B, and of   D-
W B and C, compared to type A. Other studies have found a higher mean BMI in 
patients with displaced ankle fractures compared to those with undisplaced fractures 
[206, 207], but these studies have not assessed the D-W classification. 
 
5.6 Preventing fractures in clinical practice  
Identification of subjects at high risk of fracture is fundamental if we are to improve 
our fracture preventing measures, and ensure that these are effective. As the population 
demographics changes, so must our strategies. Some of the changes having been 
discussed in this dissertation are: the aging population, and subsequently, the increased 
number of major osteoporotic fractures, the increasing number of patients being 
diagnosed with celiac disease in adulthood, and the obesity epidemic. But these factors 
are small pieces in a huge puzzle, and it may be argued that small pieces have little 
impact. They are however, all interconnected, as illustrated in Figure 15. And for each 
step on the path to a better understanding of interactions between different factors, the 
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Figure 15: Wide perspective “upstream-downstream” illustration of fractures. 







6.  METHODOLOGICAL CONSIDERATIONS 
6.1 Study design 
The results presented in this thesis are based upon a case-control study, designed as an 
epidemiological research project with the main goal to identify subgroups in 
populations being at high risk of fracture.  
A case-control study is appropriate for investigating a suspected risk factor for a 
certain outcome, especially when the latency period between the exposure we want to 
examine (CD) and the possible outcome (fracture) is long. In the design phase of the 
study, we had the research question presented in Paper II as the main focus. Based on 
available literature, we assumed a prevalence of CD (by positive TG2 or known CD) 
to be 1 % in the general population, and 5 % in the fracture patient group. Our results, 
however, showed 1 % prevalence in the general population and 2.5 % in the fracture 
patient group. Thus, we recalculated the sample size and realized that we would need 
to enlarge the study to include 1000 controls and 2000 fracture patients. This was 
unfortunately not possible to achieve within the time limits of the PhD period, both in 
terms of financial reasons (PhD scholarship) and the estimated strain on the 
rheumatology outpatient clinic.  
In papers III and IV, we described and compared the prevalence of clinical risk factors 
for the two included fracture types (the outcome variables for Paper III being distal 
radius fracture and the AO classification subgroup, ankle fracture and D-W 
classification subgroup in Paper IV). The epidemiology of ankle fractures and radius 
fracture differ. The most apparent difference found in our study was that distal radius 
fractures are strongly associated with osteoporosis, while ankle fractures are not. This 
may have diluted the results regarding increased fracture risk in CD addressed in Paper 
I, since the main reason for the increased fracture risk in CD is believed to be mediated 
through osteoporosis.  
Since all the information was collected at the clinic visit, we were not able to study 
incidence, absolute risks or causality. As in all case-control studies, possible biases 
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must be carefully considered. This applies both to possible recall bias and selection 
bias (discussed in section 6.2.1).  
6.2 Internal validity 
The internal validity of a study is “the extent to which you can be confident that a 
cause-and-effect relationship established in a study cannot be explained by other 
factors” [208]. In order to ensure high internal validity, the three essential systematic 
errors (selection bias, information bias and confounding) must be considered. 
6.2.1 Selection bias 
Selection bias may occur at the time of recruitment of subjects. Selection errors can be 
related to the willingness of the patients and controls to participate. We invited patients 
and controls to participate in a study performing DXA scans. Patients with fracture, or 
controls, already having being diagnosed with osteoporosis, could have chosen not to 
participate in the study, thinking this would not be useful for them. This might have 
caused an underrepresentation of subjects with osteoporosis, and consequently, may 
have led to a possible underestimation of the difference in BMD between patients and 
controls. Following this line of thinking, a lower proportion of participants with 
osteoporosis discovered, might also have led to a lower number of CD cases identified. 
Since fracture patients were asked face to face if they wanted to participate in the 
study, while the controls were invited by letter only, this might have caused some 
selection bias. Another aspect to consider, is that those agreeing to participate might 
have thought that this would be relevant for them, e.g. because of close family 
members with osteoporosis or CD. We unfortunately do not have any information on 
the non-attendees, rendering the degree of this possible selection bias unknown.  
When inviting population-based controls, there is a possibility that individuals with 
better health and with a high degree of health awareness are more likely to participate 
than people with poorer health and a more unfavorable lifestyle. Such individuals can 
often have a healthy life style and few comorbidities, making the control group less 
likely to have osteoporosis than the population in general. We did not compare patients 
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and controls regarding socioeconomic status (level of education, average income or the 
number receiving social benefits) or self-perceived health, which may act as surrogate 
markers for general health. For many of the participants, the visit to the hospital clinic 
demanded traveling as much as four hours by means of private or public transport, 
again favoring the more healthy individuals. We did, however, in order to diminish 
this possible selection bias, offer to cover travel expenses, also when transportation by 
taxi was needed. 
6.2.2 Information bias 
Information bias is “bias that arises from systematic differences in the collection, 
recall, recording or handling of information used in a study. Major types of 
information bias are misclassification bias, observer bias, recall bias and reporting 
bias” [209].  
Data collected through the questionnaire at inclusion could be subject to recall bias, 
and subsequently both under- and over reporting. E.g., information on smoking, 
alcohol intake and the use of some on demand medication can be under-reported, 
while information of physical activity can be over-reported. There is, however, no 
reason to suspect that this possible under- or over reporting would differ between 
patients and controls in this study.  
All BMD measurements were performed on the same GE Lunar DXA device by the 
same technician, using a standardized procedure. This should have reduced the risk of 
observational bias of BMD values. Regarding Papers III and IV, misclassification of 
the radiological images is another possible source of information bias. However, all 
interpretations were done by the same experienced radiologist, reducing inter-observer 
variability, and the intra-observer reliability of the classification systems have been 
shown to be satisfactory [210, 211].  
The main sources of possible information bias in our study affect mainly Paper 2, and 
is concerning 1) the CD serum analyses and 2) the way we defined CD in our 
statistical models. As described in section 3.3.3, the TG2 analyses were performed by 
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three different laboratories using different methods, and there were small differences 
in sensitivity and cut-off levels between the different techniques used. In Paper 2, we 
defined a positive TG2 as a strong marker for likely CD. This is a sensitive and 
reliable test, as discussed in section 1.8, but the gold standard for diagnosing CD in 
adults is duodenal biopsy. The participants in the study having a positive TG2 were 
referred to the gastroenterological department for further examination, but this data 
were not included in the study.  
6.2.3 Confounding 
Confounding is “a distortion in the estimated measure of association that occurs when 
the primary exposure of interest is mixed up with another factor that is associated with 
the outcome” [212]. It is therefore important to be aware of the possible confounders, 
and statistically adjust for them to make sure your results show true associations. We 
have included potential confounding variables in the different analyses according to 
clinical risk factors addressed in previous studies, and according to our own clinical 
experience. In paper II and IV, we adjusted for age and sex. In Paper II we additionally 
tested adjustment for other possible confounders (BMI, Vitamin D and smoking), 
which did not significantly affect the results. In Paper III, we adjusted for age, sex, 
BMI, smoking, BMD and low energy trauma. None the less, we can not rule out that 
some data may have been insufficiently controlled for, and there may be residual 
confounding. We have analyzed some variables both as categorical (e.g. osteoporosis, 
osteopenia or normal BMD) and as continuous (e.g. BMD total hip), which did not 
lead to significantly different results.  
6.3 Generalizability 
The external validity or generalizability of a study is to what degree the results can be 
extrapolated to populations other than those under study. We aimed for the results to 
be generalizable to all the inhabitants of Sogn & Fjordane county 40 years and older, 
and as a consequence of the study’s inclusion procedures, we think this has been 
achieved. Systematic studies on the prevalence of CD in Norway or different regions 
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within the country, has to our knowledge not been performed. We can therefore not 
know if our findings are generalizable to other parts of Norway or Norway as a whole.  
BMD values have been shown to differ between regions in Norway [175]. There has 
been shown ethnic differences in risk of hip fracture in Norway, all immigrant groups 
having a lower risk of hip fracture compared to the Norwegian-born [213]. None of the 
study participants in the FABB-study had an immigrant background due to population 
structure. A study by Solbraa et al, found that the population in Sogn & Fjordane were 
significantly more physically active compared to the rest of Norway [214]. The same 
study also found a higher prevalence of overweight or obesity in Sogn & Fjordane 
county (52.7 % compared to 48.3 % in Norway as a whole). These studies may 
indicate that the population of Sogn & Fjordane county in some aspects differ from the 
general population in Norway, which may affect the generalizability of our results.  
6.4 Strengths and limitations 
The county of Sogn & Fjordane has a stable population with little migration. The 
controls were from the same geographic area as the patients and examined in the same 
period of time, strengthening the comparability between groups with regard to 
potential drift in DXA and laboratory analyses. We chose population-based controls in 
order to reduce the risk of sampling bias. A large number of variables were collected, 
and the information on potential confounding factors was extensive.  The study 
included both men and women, with no upper age limit. Setting the cutoff as low as 40 
years was done in order to capture potential secondary osteoporosis, as in e.g. CD, in 
an early phase. Inclusion and examination of patients was performed only at one study 
site, ensuring that the same procedures were followed. The fact that only two 
clinicians were directly involved in collecting and registering of all data should also 
strengthen data consistency. All participants had a 30-minute session with one of these 
two rheumatologist, the questionnaire was reviewed together with the patients in order 
to clarify any misinterpretations. All DXA scans were performed by the same 
technician on one single machine, and all the radiological interpretations were 
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performed by one experienced radiologist. An additional strength in Paper III, is the 
availability of a supplementary CT scan in 68 % of the distal radius fractures. 
In addition to the possible selection- and information biases discussed in section 6.2.1 
and 6.2.2, the main limitation in the study is the lack of statistical power. The study 
was too small and statistically underpowered to yield significant results in Paper II. 
Another factor that might have affected the results presented in Paper II, is the female 
predominance among participants. Women have a higher risk of fracture in general, 
however, studies suggest that men with CD may have a higher risk of fracture than 
women with CD [134, 215]. And, as there are relatively few male subjects in our 
study, this may have diluted a potential difference in fracture risk between the CD and 
the non-CD groups. Regarding Paper III and IV, the FABB-study was not primarily 
designed to investigate the associations between variables such as osteoporosis and 
overweight and the radiological classification systems of distal radius- and ankle 
fractures. The study is underpowered to conclude on some aspects since there are few 
cases of some fracture subtypes, and no formal power analyses were performed.  
Another limitation is the use of radiological classification systems as a surrogate for 
clinical severity of a fracture, which is a far more complex entity, and the classification 
systems are not able to capture all the facets concerning the patients’ post-fracture 
challenges and functional outcome. For Papers III (AO-classification of distal radius 
fractures) and IV (using the D-W classification of lateral malleolar fractures), we 
chose to combine the B and C fracture subgroups, making the assumption that these 
fracture subtypes were more complex and being more prone to instability and need of 
surgical intervention than the fractures in the Type A category. It may also be that the 
two fracture classification groups we combine (fractures Type B and C) differ both in 
the typical trauma mechanism responsible for the injury, and in the “typical” patient 
for the specific fracture (e.g., the distal radius AO Type B fracture being relatively 
more common in men, and less often resulting from a low energy trauma, compared to 
Types A and C).  
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7.   CONCLUSIONS AND CLINICAL IMPLICATIONS 
There is a positive association between CD and risk of fracture. In our study, fracture 
patients had an odds ratio of 2.5 for a positive IgA TG2 serology test, a sensitive 
marker for CD. Our results support recommended clinical practice in Norway to be 
aware of CD as a common cause of secondary osteoporosis and fracture, and examine 
patients with CD-serology tests if suspicion arises. This case finding strategy will lead 
to more CD diagnoses being made. Initiating treatment with gluten-free diet and 
considering the patient for osteoporosis assessment, can prevent fractures. The 
increased fracture risk in CD is, however, moderate, and does not warrant systematical 
screening for CD in all adult patients presenting with fracture.  
We found that the prevalence of osteoporosis was significantly higher in the distal 
radius fracture group than in the healthy controls. This is in line with previous studies, 
and confirms the close association between osteoporosis and distal radius fractures in 
adults, and supports the current guidelines when it comes to assessment of 
osteoporosis in order to prevent the next fracture from occurring. However, 
osteoporosis did not significantly increase the odds of ankle fractures, and such a 
fracture, even if sustained through a low-energy trauma mechanism, does not 
automatically indicate the need for further osteoporosis assessment. Higher BMI and 
male sex were identified to significantly increase the odds of ankle fractures in adults. 
In order to see if the subtype of distal radius or ankle fractures could add information 
as to which fracture patients were at greater risk of osteoporosis, we looked at the AO 
subtypes of distal radius fracture, and the D-W classification system of distal fibula 
fractures. The patients with osteoporosis did not have increased odds of a more 
complex distal radius fracture compared to patients with osteopenia or normal BMD. 
Therefore, the AO-classification of distal radius fractures cannot be used to decide 
which patients should, or should not, be referred to further osteoporosis assessment. 
The same result was found in the case of the D-W classification subtypes of ankle 
fractures. The major risk factor for instability of a sustained distal fibula fracture was 
overweight and obesity, explained by the increased force a higher body weight adds to 
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the trauma mechanism. Overweight is a risk factor for certain types of fractures. But 
preventing or treating osteoporosis in patients who are overweight will probably not 
prevent ankle fractures. Fighting the obesity epidemic in society is of greater 
importance, and, taking measures to prevent falls and traumas. We also believe that 
increased mobility, balance and muscle strength in persons who are overweight will 
decrease the probability of falls, and of ankle fracture.  
This work has mainly had a clinical aim, wanting to contribute to better tailored 
fracture risk assessment. We have touched upon the decisions needing to be made by 
both orthopedic surgeons, gastroenterologists, rheumatologist, general practitioners, 
patients, and by policy makers. Categorical advice is essential for impact, but we 
should never lose sight of the personal clinical decision needing to be made together 
with the individual at risk.  
  
8.   FUTURE STUDIES  
The use of BMD values as the sole determinant of bone strength is challenging. In the 
case of CD, an impairment in bone microarchitecture using TBS has been 
demonstrated (27, 28). We did not have this software available at the time of the 
inclusion of study participants, and larger studies looking at TBS and fracture risk in 
patients with CD would be useful. The same applies for patients with overweight and 
obesity, where the comparison to the reference population in the DXA machine, with a 
lower mean BMI, is a concern when it comes to validity. The additional estimation of 
total body fat mass and various body composition estimates as part of the DXA 
procedure could also be of interest when attempting to estimate bone health and 
fracture risk in this group of patients, and there is a need for further research in order 
to establish the optimal approach.    
The use of both TBS, and perhaps also bone formation and reabsorption markers (such 
as P1NP and CTX) and OPG antibodies, could perhaps add to the predictive value of a 
bone health assessment. To our knowledge, studies looking at TBS scores and severity 
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of fractures have not been performed, and could also contribute with valuable insights 
regarding the epidemiology of fracture subtypes. In the distal radius fracture patients, 
it would be interesting to see if additional measurement of BMD in the distal radius by 
DXA could add to the risk assessment, both for risk of fracture, and to risk of specific 
fracture subtypes. A recent study performed additional DXA of the distal 1/3 of the 
radius on patients with celiac disease [216], and recommends adding this to the 
standard DXA analysis of lumbar spine and hips in patients with CD, in order to avoid 
underestimation of osteoporosis.  
The effect of treatment with anti-resorptive medication for osteoporosis in patients 
with CD has not been systematically reviewed, and such studies would be useful for 
this large groups of patients. Previous small studies have indicated no differences 
between gluten-free diet alone and diet plus bisphosphonates (35, 36).  
Findings from this thesis are not sufficient to establish if there truly is an association 
between osteoporosis and ankle fracture, and larger studies are needed in order to 

















1. Information poster 
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2. Information given to fracture patients 
FORESPØRSEL OM Å DELTA I  
FABB-STUDIEN: 
Forekomst Av Benskjørhet og Blodprøvemarkør på cøliaki hos pasienter med 
underarms- og ankelbrudd i Sogn og Fjordane. 
Du har fått påvist et brudd i underarm eller ankel. Slike brudd kan hos noen skyldes benskjørhet (osteoporose), 
og det er vist at spesielt underarmsbrudd kan være første tegn på denne tilstanden. Statens legemiddelverk og 
verdens helseorganisasjon (WHO) anbefaler at alle som har gjennomgått underarmsbrudd etter fylte 50 år 
utredes med bentetthetsmåling for å avsløre mulig underliggende osteoporose. Risiko for fremtidige brudd kan 
reduseres dersom benskjørhet diagnostiseres og behandles. Ved revmatologisk poliklinikk i Førde utreder vi 
personer med hensyn til benskjørhet og gir råd om behandling. 
Cøliaki er en tynntarmssykdom der inntak av gluten gir betennelse i tynntarmsslimhinnen og gir økt risiko for 
nedsatt beintetthet.  Hovedsymptomene er mageplager, jernmangel og trøtthet.  Mange har derimot lite eller 
ingen plager. Det er likevel viktig å oppdage sykdommen, blant annet gir cøliaki en liten økning i risiko for 
enkelte typer kreft. Behandlingen er livslangt glutenfritt kosthold. Positiv blodprøve på et antistoff mot et enzym 
som omdanner gluten i tarmen, vevsglutaminase, gir sterk mistanke om denne tilstanden.  
Vi ønsker å undersøke om pasienter i Sogn og Fjordane over 40 år med brudd i underarm eller ankel har 
benskjørhet som trenger behandling. Videre ønsker vi å se på hvor stor andel av de med brudd som har 
underliggende cølaki. Vi måler bentetthet på revmatologisk poliklinikk. Dette er en røntgenundersøkelse som er 
riskofri og tar ca 20 minutter. Samme dag vil det bli tatt blodprøver med tanke på påvisbare årsaker til 
benskjørhet, inkludert den nevnte prøven der utslag gir mistanke om cøliaki. Det vil også bli fryst ned en 
blodprøve til senere analyse av eventuelle nye markører som kan forklare årsak til osteoporose, cøliaki eller 
brudd. Dersom det senere blir aktuelt å bruke disse fryseprøvene til forskning, må det innhentes godkjennelse fra 
Regional Etisk Komite om dette. Du vil bli bedt om å svare på et spørreskjema om bl.a tidligere sykdommer, 
kosthold og medikamentbruk. Du vil også bli bedt om å underskrive en samtykkeerklæring slik at resultatene kan 
brukes i forskningen. Opplysningene som er registrert vil bli oppbevart i minimum 10 år. Alle opplysninger fra 
deg vil bli behandlet konfidensielt, og oppbevares i avidentifisert form. En kode knytter deg til dine 
opplysninger. Du kan når som helst be om å få innsyn i hva som er registrert om deg og trekke deg fra prosjektet 
om du vil det.  
Ønsker du å delta i studien, vil behandlende lege i akuttmottak eller på ortopedisk poliklinikk henvise deg til oss. 
Det vil bli kostnad som vanlig egenandel, og du har rett til å få dekket reiseutgifter som ved en vanlig poliklinisk 
undersøkelse. Ønsker du ikke å delta i studien, men likevel få målt bentetthet, kan du be behandlende lege eller 
fastlegen din om henvising til revmatologisk poliklinikk etter vanlige retningslinjer. 
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Dersom du skulle få påvist benskjørhet vil vi tilby etablert behandling for å kunne forebygge nye brudd i 
fremtiden. Dersom det er utslag på blodprøven som gir mistanke om cøliaki, anbefaler vi at vi får henvise deg 
videre til medisinsk poliklinikk for gastroskopi. Det er en kikkertundersøkelse av magesekken der en kan ta en 
liten prøve av tolvfingertarmen for å bekrefte eller avkrefte mistanken om foreligger cøliaki. Dette er imidlertid 
ikke et krav, men noe som vil bli diskutert med deg.  
Vi håper du kan tenke deg å delta i vår studie, og ser frem til å møte deg på revmatologisk poliklinikk. Dersom 
du er i tvil på om du ønsker å delta i studien er du velkommen til å ta kontakt med revmatologisk poliklinikk på 
telefon 57839381 og be om å få snakke med dr Hjelle eller dr Mielnik for ytterligere informasjon.  
Med vennlig hilsen 
Anja Myhre Hjelle 
Konstituert overlege Revmatologisk avdeling 
Førde Sentralsykehus 
 
3. Information given to controls 
FORESPØRSEL OM Å DELTA I  
FABB-STUDIEN: 
Forekomst av benskjørhet og blodprøvemarkør på cøliaki hos pasienter med 
underarms- og ankelbrudd i Sogn og Fjordane. 
Vi skal i denne studien undersøke om pasienter med brudd har større risiko for benskjørhet (osteoporose) og 
cøliaki. I den forbindelse trenger vi friske kontroller å sammenligne med. Du har blitt utvalgt tilfeldig gjennom 
Statistisk Sentralbyrå, og inviteres dermed til å delta i studien. Det er mange som har osteoporose som ennå ikke 
har hatt brudd, og risiko for fremtidige brudd kan reduseres dersom benskjørhet diagnostiseres og behandles. 
Ved revmatologisk poliklinikk i Førde utreder vi personer med hensyn til benskjørhet og gir råd om behandling. 
Dersom du har hatt brudd i armer, bein (brudd i fingre og tær er ingen hindring) eller rygg kan du ikke 




Cøliaki er en tynntarmssykdom der inntak av gluten gir betennelse i tynntarmsslimhinnen og gir økt risiko for 
benskjørhet. Hovedsymptomene er mageplager, jernmangel og trøtthet.  Mange har derimot lite eller ingen 
plager. Det er likevel viktig å oppdage sykdommen, blant annet gir cøliaki en liten økning i risiko for enkelte 
typer kreft. Behandlingen er livslangt glutenfritt kosthold. Positiv blodprøve på et antistoff mot et enzym som 
omdanner gluten i tarmen gir sterk mistanke om denne tilstanden.  
Vi inviterer deg til å få utført bentetthetsmåling på revmatologisk poliklinikk i Førde. Dette er en 
røntgenundersøkelse som er risikofri og tar ca 20 minutter. Samme dag vil det bli tatt blodprøver med tanke på 
påvisbare årsaker til benskjørhet. Det vil også bli fryst ned en blodprøve til senere analyse av eventuelle nye 
markører som kan forklare årsak til osteoporose, cøliaki eller brudd. Dersom det senere blir aktuelt å bruke disse 
fryseprøvene til forskning, må det innhentes godkjennelse fra Regional Etisk Komite om dette. Du vil bli bedt 
om å svare på et spørreskjema om blant annet tidligere sykdommer, kosthold og medikamentbruk. Du vil også 
bli bedt om å underskrive en samtykkeerklæring slik at resultatene kan brukes i forskningen. Opplysningene som 
er registrert vil bli oppbevart i minimum 10 år. Alle opplysninger fra deg vil bli behandlet konfidensielt, og 
oppbevares i avidentifisert form. En kode knytter deg til dine opplysninger. Du kan når som helst be om å få 
innsyn i hva som er registrert om deg og trekke deg fra studien om du vil det.  
Ønsker du å delta i studien ber vi deg returnere svarslippen på neste side. Du har rett til å få dekket reiseutgifter, 
og det vil ikke bli kostnader for deg ved selve undersøkelsen. Vi kan ikke dekke tapt arbeidsfortjeneste for 
undersøkelsesdagen.  
Dersom du skulle få påvist benskjørhet vil vi tilby etablert behandling for å kunne forebygge brudd i fremtiden. 
Dersom det er utslag på blodprøven som gir mistanke om cøliaki, anbefaler vi at vi får henvise deg videre til 
medisinsk poliklinikk for gastroskopi. Det er en kikkertundersøkelse av magesekken der en kan ta en liten prøve 
av tolvfingertarmen for å bekrefte eller avkrefte mistanken om cøliaki. Dette er imidlertid ikke et krav.  
Vi håper du kan tenke deg å delta i vår studie, og ser frem til å møte deg på revmatologisk poliklinikk. Dersom 
du er i tvil på om du ønsker å delta i studien er du velkommen til å ta kontakt med revmatologisk poliklinikk på 
telefon 578 39381 og be om å få snakke med dr Hjelle eller dr Mielnik for ytterligere informasjon.  
Med vennlig hilsen 
Anja Myhre Hjelle 





Ja, jeg ønsker å delta i studien. Jeg mottar dermed innkalling til undersøkelse i posten, og får samtidig 
spørreskjema og samtykkeskjema til utfylling.  
Sted: ______________ 
Dato: ______________ 
Navn (blokkbokstaver):  ______________________________ 
Signatur:  _______________________ 
__________________________________________________________________________ 
Sendes i vedlagt frankert konvolutt. 
                                                      
 
4. Consent form 
SAMTYKKESKJEMA FOR DELTAKELSE I  
FABB-STUDIEN: 
Forekomst av benskjørhet og blodprøvemarkør på cøliaki hos pasienter med underarms- og ankelbrudd i Sogn og 
Fjordane. 
Prosjektleder: Pawel Mielnik 
Forskningsmedarbeier: Anja Myhre Hjelle 
Prosjektnummer: 970114 
Viser til utdelt informasjonsskriv angående studiens bakgrunn, hensikt og gjennomførelse. 
Hva skjer med prøvene og informasjonen om deg? 
Det er frivillig å delta i studien. Om du nå sier ja til å delta, kan du senere når som helst og uten å oppgi noen 
grunn, trekke tilbake ditt samtykke. Prøvene og informasjonen som registreres om deg skal kun brukes slik som 
beskrevet i hensikten med studien. Opplysningene som er registrert vil bli oppbevart i minimum 10 år. Alle 
opplysninger fra deg vil bli behandlet konfidensielt, og oppbevares i avidentifisert form. En kode knytter deg til 
dine opplysninger. Det er kun autorisert personell knyttet til prosjektet som har adgang til opplysningene. 
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Informasjon om dine rettigheter 
      a) Personvern 
Opplysninger som registreres om deg er resultat på bentetthetsmåling, blodprøvesvar og svar som er 
angitt på spørreskjemaet. De konfidensielle data er lagret på Helse Førdes forskningssverver. 
Databehandlingsansvalig er Helse Vest IKT. 
b) Biobank 
En del av blodprøven som tas undersøkelsesdagen vil bli lagret i en forskningsbiobank ved Førde 
sykehus. Dette med tanke på å senere kunne undersøke blodet med tanke på nye faktorer i mekanismene 
bak osteoporose og/eller cøliaki, inkludert genetiske faktorer.  Dersom du sier ja til å delta i studien, gir 
du også samtykke til dette. Biobanken planlegges å vare i minimum 10 år. Etter avsluttet periode vil 
materiale og opplysninger bli ødelagt etter interne retningslinjer.  
c) Utlevering av materiale og opplysninger til andre 
Hvis du sier ja til å delta i studien, gir du også ditt samtykke til at prøver og avidentifiserte opplysninger 
utleveres til samarbeidende forskere i Helse Vest. 
d) Rett til innsyn og sletting av opplysninger om deg og sletting av prøver 
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om 
deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du 
trekker deg fra studien, kan du kreve å få slettet innsamlede prøver og opplysninger, med mindre 
opplysningene allerede er inngått i analyser eller brukt i vitenskapelige publikasjoner. 
      e) Økonomi og rolle  
Pasienter med brudd betaler etter henvisning til bentetthetsmåling vanlig egenandel for undersøkelse og 
legekonsultasjon ved revmatologisk poliklinikk. Kontroller uten brudd blir undersøkt uten kostnad, men 
ved evt oppfølging etter positive funn vil det bli krevd egenadel etter vanlige retningslinjer.  Prosjektet 
fikk tildelt forskningsmidler fra Helse Førde i 2011.  
f) Forsikring  
Personer som deltar i studien er dekket av pasientskadeerstatningsordninger ved eventuelle uhell eller 
komplikasjoner. 
Samtykke til deltakelse  
Jeg er villig til å delta i studien.    Signatur prosjektmedarbeider 
Sted: __________________ 
Dato: __________________    Dato: _________________ 
Signatur: _________________________  Signatur: ________________  
 81




6. Questionnaire  
 
SPØRRESKJEMA TIL DELTAGERE I  
 
Forekomst Av Benskjørhet og Blodprøvemarkør på cøliaki hos 
pasienter med underarms- og ankelbrudd i Sogn og Fjordane. 
Sett kryss i ruten som svar. Ved feil og du har behov for å rette, fyll ut feil valgt rute slik: ■, 
og sett dine initialer bak rettelsen. Signer etter fullført skjema med initialer og dato, ikke 
med fullt navn.  
1) Arv 
a)  Har din mor hatt brudd etter overgangsalderen?  Ja      Nei      Vet ikke   
b)  Har din far hatt brudd etter 40-årsalderen?  Ja      Nei      Vet ikke   
c)  Hvor mange søsken har du?    Antall:____ 
d)  Har en eller flere av dine søsken hatt brudd etter  
 40-årsalderen?     Ja      Nei      Vet ikke   
e)  Har du cøliaki?      Ja      Nei      Vet ikke   
f)  Kjenner du til 1.gradsslektninger (forelder, søsken 
 eller barn) har cøliaki?     Ja      Nei      Vet ikke   





a)  Hvor mye melk drikker du? 
> 0,5 liter daglig   daglig < 0,5 liter   sjeldent eller aldri   
b)  Hvor ofte spiser du hvitost (antall høvlede osteskiver): 
mer enn 3 skiver daglig   mindre enn 3 skiver daglig   aldri   
c)  Tar du vitamintilskudd?       Ja      Nei      Vet ikke   
d)  Tar du kalk?         Ja      Nei      Vet ikke   
e)  Tar du D-vitaminer?      Ja      Nei      Vet ikke   
f)  Tar du tilskudd av omega3/tran/selolje?   Ja      Nei      Vet ikke   
g)  Hva er din nåværende høyde?  ____________ meter 
h)  Hva var din høyeste målte høyde?   ____________ meter 
i)  Hva veier du?    ____________ kg 
 
3) For deg som har hatt nylig brudd: Skademekanisme 
Hvordan skjedde bruddet? 
   Lavenergibrudd (energi tilsvarende fall fra egen høyde eller lavere, evt uten skade) 
  Høyenergibrudd (mer kraft i skademekanismen enn som definert over) 
  Skadested utendørs 
  Fall på snø/is 
Hvilken måned skjedde skaden i? __________________ 
4) Spørsmål om tidligere brudd 
a) har du hatt brudd tidligere?   Ja      Nei     
 i)  hvor? _________________________________________ 
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 ii) i hvilken alder? _________________________________ 
5) Spørsmål om fysisk aktivitet 
 
Meget anstrengende aktivitet er aktivitet som krever hard innsats og som får deg til å puste 
mye mer enn vanlig. Ta bare med aktiviteter som varer minst 10 minutter i strekk. 
a) Hvor mange dager i løpet av de siste 7 dagene har du drevet med meget anstrengende 
fysisk aktivitet som tunge løft, gravearbeid, aerobics, løp eller rask sykling? 
 
_________ dager   ingen meget anstrengende aktivitet → gå rett til spørsmål c) 
b) Hvor lang tid brukte du vanligvis på meget anstrengende fysisk aktivitet på en av disse 
dagene? 
 
_________ timer per dag _________ minutter per dag   vet ikke/usikker 
Middels anstrengende aktivitet er aktivitet som krever moderat innsats og får deg til å 
puste litt mer enn vanlig. Ta bare med aktiviteter som varer i minst 10 minutter i strekk. 
c) Hvor mange dager i løpet av de siste 7 dagene har du drevet med middels 
anstrengende fysisk aktivitet  som å bære lette ting, jogge eller sykle i moderat tempo? 
Ikke ta med gange. 
 __________ dager   ingen middels anstrengende aktivitet → gå rett til spørsmål e) 
d) Hvor lang tid brukte du vanligvis på middels anstrengende fysisk aktivitet på en av 
disse dagene? 
 
_________ timer per dag _________ minutter per dag   vet ikke/usikker 
Tenk på tiden du har brukt på å gå de siste 7 dagene. Dette inkluderer gange på jobb og 
hjemme, gange fra er sted til et annet eller gange som du gjør på tur eller som trening på 
fritiden.  
e) Hvor mange dager i løpet av de siste 7 dagene gikk du i minst 10 minutter i strekk? 
 
__________ dager    gikk ikke → gå rett til spørsmål g) 
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f) Hvor lang tid brukte du vanligvis på å gå på en av disse dagene? 
 
_________ timer per dag _________ minutter per dag   vet ikke/usikker 
Det neste spørsmålet omhandler sitting. Inkluder tid du har brukt på å sitte på jobb, 
hjemme, på kurs og på fritiden. Dette kan tilsvare tiden du sitter ved et arbeidsbord, hos 
venner, mens du leser, eller sitter eller ligger for å se på TV. 
g) Hvor lang tid brukte du på å sitte på en vanlig hverdag i løpet av de siste 7 dagene? 
 
_________ timer per dag _________ minutter per dag   vet ikke/usikker 
h) Tenk tilbake i tid. Hvor ofte drev du med fysisk aktivitet eller idrett så mye at du ble 
andpusten og/eller svett da du var: 
Sett ett kryss for hver aldersgruppe 
    Under 10 år  10-14 år 15-20 år 20-30 
år  
Aldri                                                 
Mindre enn en gang/måned                                                
  
1-3 ganger/måned                                                         
  
1 gang/uke                                          
 
2-3 ganger/uke                                         
4-6 ganger/uke                                           
Hver dag                                          
 
6) Spørsmål om hormoner (besvares kun av kvinner) 
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a)  Hvor gammel var du da du fikk din første menstruasjon? ______ år 
b) Har du hatt regelmessig menstruasjon?      Ja   Nei 
c) Har du gjennomgått underlivsoperasjon?    Ja   Nei 
 i)  i hvilken alder? _________ år 
 ii)  ble eggstokkene fjernet?   Ja      Nei      Vet ikke   
d)  Har du passert overgangsalderen?  Ja      Nei      Vet ikke   
 i) ved hvilken alder? _________ år 
e) Har du fått hormonbehandling i forbindelse med overgangsalderen?  
    Ja      Nei      Vet ikke   
i) hvilket årstall fikk du hormonbehandling? _______  
ii) var det stikkpiller/krem   tablett    plaster   
iii) får du fortsatt hormoner?  Ja      Nei       
iv) hvilken hormonbehandling får du (navn på medikament)? ________________ 
 
7) Spørsmål om annen sykdom 
 
Angi hvilke av sykdommene nedenfor du har, og ved hvilken alder du fikk diagnosen: 
  Sukkersyke/diabetes   ___________ år 
  Stoffskiftesykdom   ___________ år 
  Leddgikt    ___________ år 
  Crohns sykdom   ___________ år 
  Ulcerøs colitt    ___________ år 
  Astma eller KOLS    ___________ år 
  Epilepsi    ___________ år 
  Andre sykdommer? Hvilke?             ___________________         ____ år 
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      ___________________  ____ år 
      ___________________  ____ år 
      ___________________ ____ år 
Til kvinner: Har du spontanabortert? 
      ja   nei   vet ikke 
 Hvis JA, antall ganger ________ 
Til menn: Har din partner noen gang spontanabortert? 
      ja   nei   vet ikke 
 Hvis JA, antall ganger ________ 
Bruker du glutenfri diett? 
      ja   nei   vet ikke 
Har du fått stilt diagnosen Dermatitis Herpetiformis? 
      ja   nei   vet ikke 
Har du fått stilt diagnosen cøliaki på bakgrunn av en vevsprøve fra tynntarmen tatt under 
en undersøkelse der du svelget en slange (gastroskopi?) 
      ja   nei   vet ikke 
8) Bruk av medikamenter 
Angi navnet på medikamenter som du nå bruker daglig.  
 
     Har du noen gang brukt Prednisolon tabletter i mer enn 3 måneder sammenhengende? 
       Ja      Nei      Vet ikke   
9) Spørsmål om røyk og alkohol 
 
a) Omtrent hvor ofte har du i løpet av det siste året drukket alkohol? 
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Lettøl og alkoholfritt øl regnes ikke med. 
   4-7 ganger i uka 
   2-3 ganger i uka 
   Ca 1 gang i uka 
   2-3 ganger per måned 
   Omtrent 1 gang per måned 
   Noen få ganger siste år 
   Har ikke drukket alkohol det siste året 
   Har aldri drukket alkohol 
b) Når du har drukket alkohol, hvor mange glass/drinker har du vanligvis drukket? 
_________  antall 
c) Omtrent hvor mange ganger i løpet av det siste året har du drukket så mye som minst 5 
glass og/eller drinker i løpet av ett døgn? 
__________ antall ganger 
d) Når du drikker alkohol, drikker du da vanligvis: 
  Øl 
  Vin 
  Brennevin 
e) Har du røykt/røyker du daglig? 
   ja, nå 
  ja, tidligere 
  aldri 
f) Hvis du har røykt daglig tidligere, hvor lenge er det siden du sluttet?   
______ år 
g) Hvis du røyker daglig nå eller har røykt tidligere:  
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I: hvor mange sigaretter røyker/røykte du vanligvis daglig? 
 _______ antall sigaretter  
II: hvor gammel var du da du begynte å røyke daglig? 
 _______ år 
III: hvor mange år til sammen har du røykt daglig? 
 _______ år 
  10) Spørsmål om mage/tarm funksjon 
     a)  I hvilken grad har du hatt følgende plager de siste 12 måneder? 
Kvalme      aldri    litt    mye 
Halsbrann/sure oppstøt    aldri    litt    mye 
Diare       aldri    litt    mye 
Treg mage      aldri    litt    mye 
Vekslende treg mage og diare   aldri    litt    mye 
Oppblåsthet      aldri    litt    mye 
Smerter i magen     aldri    litt    mye 
 
    b)  Hvis du har hatt smerter i eller ubehag fra magen det siste året: 
            Er disse lokalisert øverst i magen?        ja   nei 
 Har du hatt plagene så ofte som 1 dag i uka eller mer de siste 3 mnd?  ja   nei 
 Blir plagene bedre etter avføring?       ja   nei 
 Har plagene sammenheng med hyppigere eller sjeldnere avføring enn vanlig? 
          ja   nei 
 90
 Har plagene noen sammenheng med løsere eller fastere avføring enn vanlig? 
          ja   nei 
 Kommer plagene etter måltid?       ja   nei 
Dato for utfylling: ____________ 
Dine initialer: ________________ 
           
Tilleggsinformasjon til Spørreskjema 
Angående spørsmål 5 Fysisk aktivitet 
Her ber vi deg svare på spørsmål om fysisk aktivitet i uken før det aktuelle bruddet, altså de 7 
dagene før bruddet skjedde. 
Mvh 
Anja Myhre Hjelle og Pawel Mielnik 
FABB-studien 





















RESEARCH ARTICLE Open Access
No association between osteoporosis and
AO classification of distal radius fractures:
an observational study of 289 patients
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Abstract
Background: It is mechanically plausible that osteoporosis leads to more severe peripheral fractures, but studies
investigating associations between BMD and radiographically verified complexity of distal radius fractures are scarce.
This study aims to study the association between osteoporosis, as well as other risk factors for fracture, and the AO
classification of distal radius fractures.
Methods: In this observational study, 289 consecutive patients aged ≥40 years with a distal radius fracture were
included. Bone mineral density (BMD) of the hips and spine was measured by dual-energy x-ray absorptiometry
(DXA), and comorbidities, medication, physical activity, smoking habits, body mass index (BMI), and history of
previous fracture were registered. The distal radius fractures were classified according to the Müller AO system (AO)
(type B and C regarded as most complex).
Results: Patients with osteoporosis (n = 130) did not have increased odds of a more complex distal radius fracture
(type B + C, n = 192)) (n = vs type A (n = 92) (OR 1.1 [95% CI 0.5 to 2.3]) compared to those with osteopenia /normal
BMD (n = 159). Patients with AO fracture types A or C had a higher prevalence of osteoporosis than patients with
type B fracture.
Conclusions: Distal radius fracture patients with osteoporosis did not sustain more complex fractures than those
with osteopenia/normal BMD according to the AO classification system. The AO classification of distal radius
fracture cannot be used to decide which patients should be referred to DXA scan and considered for secondary
fracture prevention.
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Background
Distal radius fractures are the most common of all frac-
tures during a lifespan. A Norwegian study found an
overall annual incidence of 19.7 per 10,000 inhabitants
16 years or older [1]. In women, the incidence of distal
radius fractures increases progressively with age from
the perimenopausal period, while in men, the incidence
remains low until later in life [2, 3]. According to the
Swedish fracture registry (www.frakturregistret.se), 19,
357 women over the age of 60 suffered a distal radius
fracture in 2018. Distal radius fractures are closely re-
lated to low bone mineral density (BMD) [4], and risk
factors for fracture also include increasing age, female
sex, low body mass index (BMI), smoking, postmeno-
pausal status, low intake of dairy products, vitamin D de-
ficiency, and autoimmune comorbidities. Patients
sustaining a distal radius fracture have an increased risk
of a major osteoporotic fracture (MOF) of the hip and
vertebrae later in life [5, 6]. According to guidelines of
fracture liaison services, a low energy fracture in an at-
risk patient (e.g. > 50 years old) should lead to further
examination with dual-energy x-ray absorptiometry
(DXA) and treatment with anti-osteoporotic drugs if in-
dicated [7].
When it comes to distal radius fractures and radio-
graphic severity a few studies have been performed [8–
12], but the number of patients examined are limited,
the methods used differ, and conclusions are not easily
drawn. Therefore, our aim was to further investigate if
there is an association between osteoporosis and other
well-known risk factors for osteoporotic fractures and
AO classification of distal radius fractures.
Methods
Subjects
From March 1, 2012 until January 13, 2017, patients
aged ≥40 years presenting with acute distal radius frac-
ture at the Department of Orthopedic Surgery at District
General Hospital of Førde (Sogn og Fjordane County)
were included in a case control study. The study was
primarily designed to explore the prevalence of celiac
disease in patients with peripheral fractures compared to
community-based controls. The original study has previ-
ously been described [13]. Fracture patients who fulfilled
the inclusion criteria and consented to participate were
referred for DXA scan and consideration of secondary
fracture prevention (n = 516). Two hundred eighty-nine
patients agreed to participate, giving an inclusion rate of
56%. We included both patients with low energy frac-
tures (equivalent to fall from standing height or lower)
and fractures due to traumas with higher energy. Five
patients suffered multiple simultaneous fractures (one
with bilateral radius fractures, one with an additional hu-
merus fracture, one with an additional ankle fracture,
and two with additional vertebral compression
fractures).
Procedures and measurements
The radiographic distal radius series comprised standard
anteroposterior and lateral radiographs. In 68% of cases
(197 of 289 patients) a supplementary CT scan was
available. The same radiologist classified the fractures as
extra articular (type A), partly articular (type B) or
complete articular (type C) according to the Müller AO-
system (AO) [14, 15]. Types B and C were considered
more complex than type A. In addition, the multifrag-
mentary fractures (types A3, C2 and C3) combined were
compared to the other AO fracture types. Five of the
distal radius fractures could not be classified because the
radiographic images had been performed elsewhere.
The BMD measurements were performed by DXA
technology (Lunar Prodigy Rtg 5603, manufacture year
2000, GE Healthcare), with a daily quality assurance of
+/− 2%. BMD was reported as g/cm2 and T-scores by
standard definition. Osteoporosis is defined as T-score ≤
− 2.5 in the femoral neck, total hip or lumbar spine.
Osteopenia (low bone mineral density) is defined as T-
score between − 1.0 and − 2.5 [16]. History of previous
fractures, comorbidities, medications, and lifestyle fac-
tors were registered. The original documents from the
orthopedic surgeons and examining rheumatologist were
reviewed to classify the injury as due to a low energy
trauma or not. Height and weight were measured as part
of the DXA procedure. BMI was calculated and catego-
rized into underweight (BMI < 18.5), normal weight
(BMI 18.5–24.99), overweight (BMI 25–29.99) and obes-
ity (BMI ≥ 30). Blood tests were analyzed to detect com-
mon causes of secondary osteoporosis [13].
Statistical analyses
We performed descriptive statistics for age, sex, BMI,
number of patients with osteoporosis, osteopenia, and
overweight in the distal radius fracture subgroups. Data
between subgroups were compared using chi square or
Fisher’s exact test for categorical data and two-sample t-
test or Mann-Whitney U test for continuous data. To as-
sess risk factors associated with the complexity of frac-
tures, we estimated odds ratios (ORs) with 95%
confidence intervals (CIs) using unconditional logistic
regression models. Complexity of fractures was defined
as more radiological complex fractures (AO type B + C)
as opposed to less complex fractures (AO type A). Rele-
vant risk factors for complexity of fracture included
osteoporosis, osteopenia, age > 65 years, male sex, BMI,
and current and previous smoking. In all analyses, the
association between the risk factor and the complexity
of fractures was first examined crudely and then with
adjustment for the other risk factors under study. All p-
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values were two-sided and values below 0.05 were con-
sidered statistically significant. All calculations were per-
formed using R version 3.6.2 (team).
Results
We found that 45.0% (n = 130) of patients with distal ra-
dius fracture had osteoporosis and 33% (n = 95) had
osteopenia (Table 1). Patients with an AO type B frac-
ture were younger, had a higher mean BMI, and the per-
centage of men was higher than in the groups with A or
C fractures (Table 1). 29.4% of patients with type B frac-
ture had osteoporosis compared to 46.7% of type A and
48.1% of type C (Table 1, Fig. 1). The patients with
osteoporosis differed from the patients with osteopenia/
normal BMD at a group level by having a statistically
lower BMI (BMI 26 vs 27, p-value 0.005), being older
(mean age 64 vs 53 years, p-value 0.01), a greater per-
centage were female (88% vs 75%, p-value 0.01), and
there was a higher prevalence of current smoking (18%
vs 13%, p-value 0.1). There was a significantly higher
proportion with low energy trauma mechanism in the
patients with radius fracture and osteoporosis compared
to those with radius fractures and normal BMD/osteope-
nia (77% vs 57%, p-value < 0.001).
The OR of sustaining a distal radius fracture type B or
C vs. A was not significantly affected by the presence of
osteoporosis (Table 2). Current smoking and low energy
trauma injury were associated with less complex frac-
tures (Table 2). When combining the multifragmentary
fractures across the classification groups (A3 + C2 + C3),
the OR of sustaining a multifragmentary fracture did not
significantly differ according to BMD status (osteopor-
osis gave an OR of 1.4 (95% CI 0.6–3.7), and osteopenia
OR 1.0 (95% CI 0.4 to 2.6)). Low energy trauma mech-
anism decreases the odds of comminuted fractures
compared to the other AO subgroups (OR for (A3 +
C2 + C3) 0.3 (95% CI 0.1–0.5)).
Discussion
The odds of sustaining a distal radius fracture Type B or
C compared to Type A in patients with osteoporosis did
not differ from those with osteopenia or normal BMD.
This indicates that the AO classification of the fracture
cannot be used to decide which patients should be re-
ferred to DXA scan and considered for secondary frac-
ture prevention. One may argue that the AO-
classification system is not able to capture all the facets
of a fracture, as many factors concern the mechanical
complexity and etiology of a fracture (e.g. the position
and angle of the extremity and the body at the time of
the fall, body composition and weight, balance, rota-
tional forces, and the surroundings). A more detailed
discussion of the classification system is beyond the
scope of the current study, which aims to investigate the
association between osteoporosis and the severity of dis-
tal radius fractures using established radiographic
methods.
Our results are in line with previous rapports. A study
including 137 patients with low-energy distal radius frac-
tures found an inverse correlation between BMD of the
hip measured 3 months after the fracture and likelihood
of early instability, late carpal malalignment and malu-
nion [10]. However, no correlation between BMD and
the AO subtypes was found. The same study found that
BMD in patients with type C fractures was higher than
in patients with type A fractures, which is in agreement
with our results. This is also supported by a study of 208
patients with distal radius fracture, where no correlation
between the AO-classification and BMD of the hips and
spine was found [11]. The authors suggested that a
Table 1 Characteristics of patients with distal radius fractures according to type of fracture (Müller AO classification system)
Fracture type
All AO type A AO type B AO type C AO type B + C
Total n 289 92 34 158 192
Age, mean (range) 63 (40–92) 62 (42–88) 62 (42–80) 64 (40–92) 64 (40–92)
Female sex, n (%) 231 (80) 78 (85) 21 (61) 128 (81) 149 (78)
Osteoporosisa, n (%) 130 (45) 43 (47) 10 (29) 76 (48) 86 (45)
Osteopeniab, n (%) 95 (33) 31 (34) 13 (38) 47 (30) 60 (32)
BMI, mean (SD) 26 (5) 26 (4) 28 (5) 26 (5) 26 (5)
Overweight, n (%) 95 (33) 27 (29) 12 (35) 55 (35) 67 (35)
Obesity, n (%) 64 (22) 21 (23) 11 (32) 28 (18) 39 (21)
Current smoking, n (%) 43 (15) 20 (22) 3 (9) 19 (12) 21 (11)
Previous smoking, n (%) 121 (42) 39 (42) 11 (32) 67 (42) 64 (41)
a T-score ≤ − 2.5
b T-score − 1.0 - -2.5
AO AO classification, BMI Body Mass Index (BMI categories: underweight BMI < 18.5, normal weight BMI 18.5–24.99, overweight BMI 25–29.55 and obesity BMI
≥30.0); SD: Standard deviation
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possible explanation for this might be that DXA mea-
sures thickness of cortical bone, which is thicker in the
metaphyseal area than in the epiphyseal area. A more se-
vere osteoporotic fracture would therefore be a meta-
physal fracture instead of an intra-articular fracture.
Dhainaut et al. [12] assessed cortical hand BMD by
digital X-ray radiogrammetry in 110 female patients with
fragility fracture at the distal radius, and concluded with
no correlation between neither BMD of the hip or spine
nor the digital X-ray radiogrammetry and the AO frac-
ture type. The only significant risk of intra-articular dis-
tal radius fracture compared to less complex fractures in
that study was ever having used glucocorticoids, sup-
porting the hypothesis that the severity is more associ-
ated with other factors comprising bone quality than
BMD.
Severity of a distal radius fracture is a clinical as-
sessment. The AO classification does not take into
consideration instability, malunion, decreased radial
length or the degree of dorsal angulation. It is clinic-
ally not clear if a complete articular fracture without
displacement (C1) is more harmful to the patient
than an extra-articular fracture with metaphyseal
comminution (A3). Clayton et al. [10] define the most
serious distal radius fracture types as A3, C2 and C3.
Subanalysis of our data did not support that osteo-
porosis leads to a higher proportion of these fractures
compared to other subtypes. We found a significantly
lower OR for low energy trauma among those with
type B or C fracture compared to type A. This illus-
trates that factors influencing fracture severity may be
complex.
Strengths and limitations
Our study was not primarily designed to investigate
the association between osteoporosis and radiological
severity of distal radius fractures. The study was
therefore underpowered to conclude on some aspects,
as there are many subtypes of fractures and accord-
ingly few fractures in some of the groups. We did,
however, have a large number of patients compared
to previous studies, and we included both women and
men. The radiographic interpretations were done by
an experienced radiologist, and the AO classification
has earlier been shown to have good intra-observer
reliability when restricted to the three main AO-types
[17]. To our knowledge no studies have shown an as-
sociation between the AO-classification, fracture se-
verity and clinical outcome. Accordingly, based on
our results the clinical severity of the fractures could
not be assessed, only the radiographic complexity. A
strength of this study was the availability of supple-
mentary CT scans in 68% of the distal radius frac-
tures. The use of CT scans may explain that there
Fig. 1 Left hip total BMD measurements box plot for distal radius
fracture subgroups.AO, AO classification. Centre horizontal line of the
boxes represents the median. The boxes contain Q1 (25th
Percentile) to Q3 (75th Percentile). IQR (Interquartile range) is the
distance between Q1 and Q3. The bottom whiskers: less than Q1–
1.5*IQR. The upper whiskers: greater than Q3 + 1.5*IQR. BMD
measurements in 9 patients missing (left hip not measurable)
Table 2 Odds Ratios (unadjusted and adjusted) for complex
(AO type B and C) vs. less complex (AO type A) distal radius
fractures
OR with 95% CI
Exposures Unadjusted Adjusted
BMI 1.0 (0.8–1.3) 1.0 (0.7–1.3)
Current smokinga 0.4 (0.2–0.9) 0.4 (0.2–0.8)
Previous smokinga 0.8 (0.4–1.3) 0.7 (0.4–1.3)
Osteoporosisb T-score≤ −2.5 0.8 (0.4–1.5) 1.1 (0.5–2.3)
Osteopeniac T-score − 1.0 - -2.5 0.8 (0.4–1.6) 1.0 (0.5–2.1)
Age > 65 yearsd 1.4 (0.9–2.4) 1.6 (0.9–2.7)
Male sexe 1.7 (0.9–3.5) 1.5 (0.7–3.1)
Low energy traumaf 0.5 (0.3–0.8) 0.4 (0.2–0.8)
OR Odds ratio, CI Confidence interval, BMI Body mass index
Relevant risk factors adjusted for were: age, sex, BMI, smoking, bone mineral
density and low energy trauma
aReference category was the non-smoking group. When analyzing current
smoking, the group of previous smoking is removed, and vice versa
bReference category was no osteoporosis (osteopenia and normal bone
mineral density)
cReference category was normal bone mineral density (T-score ≥ − 1.0)
dReference category was age < 65
eReference category was female sex
fReference category was no low energy trauma
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were more AO type C fractures in our study, com-
pared to other studies reporting more type A
fractures.
Conclusions
In this study, severity of distal radius fractures according
to the AO-classification of distal radius fractures was
not associated with osteoporosis when adjusted for age,
sex, and BMI. AO-classification of distal radius fractures
cannot be used to identify which patients should be eval-
uated and treated for osteoporosis.
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